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Key definitions 
 
a) Coordination: processes which are often led by the Secretariat of UNASUR to ensure that 
the specific collective objectives are carried out. 
b) Disparities: Contextual differences between the Member Countries of UNASUR which may 
affect the adopting/ implementation of regional policies and regulations nationally. 
c) Governance: The functions related to the management, coordination and development of 
regulations implemented by governments and by decision makers in their attempt to attain 
health objectives.  
d) Harmonisation: Process of facilitating the alignment and achievement of UNASUR goals 
which are included in the governing documents of UNASUR. 
e) Health: “a state of complete physical, mental and social wellbeing and not merely the 
absence of disease or illness (WHO).” 
f) Input indicators: Indicators that measure human resources, financial resources, physical 
infrastructure, equipment and any other resources related to the application of a policy and 
programme.  
g) Process indicators: They evaluate whether the policy or programme is being applied as 
planned and how well the policy or programme activities are being carried out.  
h) Output indicators: They relate to the results of the efforts (inputs and processes/activities) 
in terms of the programme or the policy. They show the direct results of the policy or 
programme activities. 
i) Outcome indicators: They measure the level of success of the programme in terms of 
improving the accessibility of services, the use or quality of the policy.  
j) Impact indicators: They measure in the long term, the cumulative effects over time of the 
policies or programmes concerning public health and wellbeing or the broader social system.  
k) Indicator levels: They refer either to the levels of measuring indicators (e.g. worldwide, 
regional, national, subnational) or to the level of production and reporting of indicators (e.g. 
worldwide (UN), regional (UNASUR, MERCOSUR, CAN, among others), (national member 
countries). 
l) Monitoring: Follow-up and evaluation process of the application and impact of the policies. 
m) Policy priorities: Key goals in the field of health.  
n) Regional health policy: Policies developed in the context of a regional organisation to 
respond to the health challenges of its Member States. 
o) Regional Integration: The process by which two or more nation-states agree to cooperate, 
harmonise policies and/or design common policies and institutions to achieve common 
objectives. 
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p) Access to primary health care: “essential healthcare which is accessible to all individuals 
and families in the community through means acceptable to them, with their full 
participation and at an affordable cost for the community and the country (WHO)”. 
q) Access to medicines: the availability, opportunity and the right to receive medication 
which is affordable and available to everyone. 
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Preface 
 
This PRARI Toolkit is the culmination of the work carried out in the area of regional 
indicators development of the project on Poverty Reduction and Regional 
Integration (PRARI), coordinated by Professor Nicola Yeates at the Open University 
(UK). The two-year project, carried out during 2014-2015, examines what regional 
institutional practices and methods of regional policy formation are conducive to the 
emergence of embedded pro-poor health strategies, and what national, regional and 
international actors can do to promote these policies.2 The work was carried out 
with support from the Economic and Social Research Council (ESRC)/ Department for 
International Development (DfID) United Kingdom, Grant Reference ES/L005336/1. It 
does not necessarily reflect the opinions of the ESRC/DfID, The Open University, or 
the United Nations University.    
 
The PRARI Toolkit is one of the most important results of PRARI. We hope that it will 
be used by different South American stakeholders -  officials of the Union of South 
American Nations (UNASUR) (including the Institute of South American Governance 
(ISAGS), which contributed to its development) and  national officials to monitor the 
regional health policies in UNASUR. This Toolkit is focused on access to primary 
healthcare and access to medicines. The indicator system has not been designed as a 
static system or as a final proposal. Its innovation consists of the participatory 
approach used to develop it in collaboration with potential users of the system.  
 
The PRARI Toolkit has been a collective effort and has benefitted from the 
contributions of many partners and participants. We would like to thank in particular 
the co-authors of this report for their participation, comments and support; Mariana 
Faria, Henri Jouval and the ISAGS/UNASUR team for welcoming us in Rio de Janeiro. 
We would also like to thank the UNASUR team that helped with the logistics of our 
                                                        
2 Further information about PRARI is available from The Open University project website: 
http://www.open.ac.uk/socialsciences/prari/index.php. Other institutional partners are the South African Institute for 
International Affairs (SAIIA), FLACSO (Argentina), Southampton University (UK), and the United Nations University Institute on 
Comparative Regional Integration Studies (UNU-CRIS).   
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Ciudad Mitad del Mundo workshop; Belén Herrero, Melisa Deciancio, Diana Tussie 
and FLACSO for welcoming us in Buenos Aires; Michel Levi and the team of the 
Andean University for receiving us in Quito; and Nicola Yeates, Tracey de Beer and 
Dawn Edwell from The Open University in Milton Keynes for their invaluable support, 
guidance and advice throughout the research. We would also like to especially thank 
Lien Jaques for his help with editing the text, figures and tables. Lastly, we would 
especially like to thank Ana Gabriela Alvarez Cruz, Maria Borda, and Alexandra 
Melissa Vida for their research assistance.  
 
Ana B. Amaya, Philippe De Lombaerde and Stephen Kingah, Bruges (Belgium), 
December 2015 
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CHAPTER 1: INTRODUCTION AND JUSTIFICATION OF THE PRARI TOOLKIT 
 
South America has experienced significant economic growth in the last decade 
(World Bank 2015). However, as with other regions, the initial stages of this 
economic growth have been associated with a greater inequality (Morrison 2000). 
There are clear links between economic inequalities and health disparities (Brown 
2000), which lead to the lack of access to health services and fewer opportunities for 
development. In South America, health systems are currently dealing with a double 
challenge:  tackling traditional health problems, such as infectious diseases, maternal 
and infant deaths and an increasing prevalence of chronic diseases, which is the 
result of the significant socio-economic change in the region (Arriagada et al., 2005). 
 
It is increasingly acknowledged that the processes and instruments of governance for 
development have to be used to improve social wellbeing. One of the elements of 
wellbeing that is often referred to is access to primary healthcare in a dignified and 
affordable way as a first step to accessing healthcare services in general. It is not by 
chance, therefore, that crucial processes such as the development of the Sustainable 
Development Goals (SDGs) assign a key weight to the promotion of a healthy life, 
including it as one of the goals (SDG3). This demonstrates the global consensus of 
the importance of access to primary healthcare as a step towards reducing 
inequalities or promoting development.  
 
The debate on the optimum level of access to primary healthcare is also significant 
(ISAGS, 2013a). While attention has often been focused on national and worldwide 
levels, there is space for expanding the interventions on a regional/supranational 
level. Health collaboration on this level has the potential to respond to transnational 
health problems through cooperation between countries. Many regional 
organisations have recognised this potential by adopting key provisions in regional 
treaties, protocols, letters and declarations. UNASUR is not an exception in this 
sense. 
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UNASUR was established in 2008 as a political constellation which brings together 
members of the Andean Community (CAN, by its Spanish acronym) and the Southern 
Common Market (MERCOSUR), along with Chile, Guyana and Suriname. The origins 
of UNASUR can be traced back to the initiative of the South American Community 
(SAC) which had been formed in Cuzco in 2004. The main driving force of the SAC 
was the former president Lula of Brazil (Malamud 2011: 6). UNASUR’s founding 
treaty of 2008 contains many targets and among them a key target is promoting 
development in the countries. The treaty explicitly states in article 3 (j) that effective 
universal access to social security and to health services is an important objective for 
the Union. It is revealing that the text relates social security with health.  The 
political leaders of the region have identified the attainment of health as one of the 
key focus areas for achieving development and reducing health inequalities in the 
region.  This is explained in part by the clear differences in the region in terms of 
access to the health services. These inequalities are placed among the highest in the 
world, with a high level of marginalisation of indigenous communities in many 
countries of the region (Vilas 2008: 118). 
 
The aim of the team constructing the indicators of the PRARI project is to facilitate 
the collaborative construction or joint development of a set of indicators that can be 
(mainly) used by regional decision makers to support them in monitoring health 
policies and their implementation. This PRARI Toolkit is, therefore, a guide to 
implementing a system of indicators to measure the scope of regional policies and 
the success of regional health policies in the context of UNASUR.  
 
The aspects related to the measurement of health policies which are measured in 
this PRARI Toolkit contain an added value for UNASUR. The reduction of disparities 
among member states is a key goal of UNASUR and a measure of integration.  This 
specific focus of UNASUR Health on health equity aims to deal with inequalities and 
in this way improve the living conditions of the whole population. This vision 
corresponds to article 2 of UNASUR’s founding treaty, which seeks to eliminate 
inequalities and achieve social inclusion: 
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“The objective of the South American Union of Nations is to build, in a 
participatory and consensual manner, an integration and union among its 
peoples in the cultural, social, economic and political fields, prioritizing 
political dialogue, social policies, education, energy, infrastructure, financing 
and the environment, among others, with a view to eliminating 
socioeconomic inequality, in order to achieve social inclusion and 
participation of civil society, to strengthen democracy and reduce 
asymmetries within the framework of strengthening the sovereignty and 
independence of the States.” (UNASUR, 2008: Article 2) 
 
The indicators have been developed with a specific focus on access to primary 
healthcare and medicines, which are cross-cutting issues that have an effect on all 
populations. The PRARI Toolkit has the aim, amongst others, to demonstrate the 
difficulties and limitations that health sectors face in many countries when trying to 
resolve structural problems that perpetuate inequalities. A crucial dimension of this 
Toolkit is to measure the degree to which regional policies aimed at dealing with 
these areas reflect an aspect of reducing inequality. The Toolkit reveals the way in 
which regional policies are translated into internal policies. 
How to use this monitoring system 
The methodology proposed in this PRARI Toolkit is characterised by its inclusive 
nature and its flexibility. As such, it is a flexible system that captures the indicators at 
a national and regional level, and which highlights the indicators associated with 
reducing inequalities with a focus on two key areas: access to primary healthcare 
and access to medicines. These indicators seek to measure accessibility in these two 
areas with a final objective of reducing inequalities and improving health. Therefore, 
the indicators have been selected taking into account the social determinants of 
health.  
 
Specific indicators which feature the Sustainable Development Goals (SDGs) are also 
included. Indicators which gauge goal 3 of the SDGs, which deals with health, as well 
as indicators provided by international organisations, are reflected mainly under 
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indicators of outcome and impact. As they complement these indicators, the PRARI 
indicators add value by identifying input, process, output and outcome  indicators.  
 
The proposed methodology presented must be considered an adaptable and flexible 
exercise which can be complemented and proportionally increased based on the 
needs identified by the end users. All the logical components have been dealt with, 
considering that additional priorities can be generated over time. Due to this, the 
PRARI Toolkit is a modular system that reflects the reality/need for interventions on 
a multi-level basis. 
 
With regard to the data collection period, it is suggested that monitoring is aligned 
with the current practice in UNASUR and in the context of other international 
organisations. In relation to the additional indicators which are not currently being 
compiled, it is suggested that the ministries of the countries and regional officials 
report this data annually.  
 
It is reiterated that this PRARI Toolkit has considered the work that has been carried 
out up to now in UNASUR (Garron et al. 2013). This Toolkit builds upon and 
strengthens these efforts with a view to filling the gaps and needs for strengthened 
monitoring in UNASUR.  
 
The experiences of constructing other systems of regional monitoring were  taken 
into account during the construction of the PRARI Toolkit (De Lombaerde, 
Estevadeordal and Suominen 2008; De Lombaerde et al. 2010). In turn, there is an 
awareness of the lack of regional monitoring activities in South America, particularly 
with regard to the development of indicator systems, compared to other regions. 
This also applies to the Andean Community and to Mercosur (Adiwasito et al. 2005; 
Prada and Espinoza 2008; Rozemberg and Bozzalla 2008). 
 
This Toolkit document consists of five chapters. Chapter 2 explains the production 
process of the indicator system and presents the actors involved. Chapter 3 provides 
an introduction to the conceptual framework and discusses some additional 
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methodological matters. Chapter 4 presents the indicators, and chapter 5 explains 
how the PRARI Toolkit can be implemented. This is followed by the list of references 
and annexes. 
 
 
CHAPTER 2: THE PROCESS OF DEVELOPING THE PRARI TOOLKIT 
 
When exploring the experiences with other monitoring systems based on indicators 
at the regional level, we find that, among other factors, local participation and 
leadership are essential for developing and implementing these types of systems (De 
Lombaerde, Pietrangeli and Weeratunge 2008; De Lombaerde et al. 2010). To 
respond to this need, the methodological approach which was used to construct 
these indicators was participatory action research (PAR) (Amaya and Yeates 2015). 
This means, among other things, that end users of the PRARI Toolkit were involved in 
its conceptualisation, development and implementation from the outset.  
 
The PAR approach was used to develop, in a collaborative way, indicators to measure 
the success and change produced by regional health policies. This approach differs 
from traditional research by considering the knowledge of local actors and 
beneficiaries of the system. In this sense, the actors who are affected by these 
policies are those who serve as a main source of information and are involved in all 
the stages of the process, such as the identification of the problem and its analysis in 
order to jointly come to solutions. In addition, this approach involves cycles of action 
and reflection, where the results and data are continually questioned and analysed. 
This makes sure that the change is lasting by ensuring that there is a learning process 
and an exchange of information (Mahoo 2012). In the same way, PAR differs from 
traditional research by giving researchers a facilitating role with a focus on 
empowering local actors to build their own knowledge and respond to their needs 
(see Amaya and Yeates 2015 for an extended discussion of the methodological 
approach of PAR).  
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The process of developing the PRARI Toolkit by means of PAR involved the formation 
of an “indicator development team” in the UNASUR region through the organisation 
of regional workshops to debate key issues. The team was composed of around 12 
key actors from the region representing universities, ministries and regional 
organisations. Although it was not possible to involve all the countries in the region 
for logistical and financial reasons, we sought to identify key actors, maintain a 
gender balance and represent various sectors. The challenges involved in this 
process included the need to promote a consensus among the team and logistical 
issues in organising interactions with different actors based in various countries and 
time limitations characteristic of a relatively short research project. 
 
 The indicators developed for the PRARI Toolkit are based on needs identified by 
actors embedded within the region. The two pilot areas were decided by consensus 
between the team building the indicators during the workshops by considering the 
priorities of UNASUR Health and the opportunity to have an impact on the work in 
the region. The first workshop (Rio de Janeiro, Brazil, November 2014), was the 
chance to debate the need of that monitoring system for the region and to draw up, 
among the majority of participants, a policy report (Amaya, Cabral, Coitiño et al., 
2015). In that policy report, the importance of a regional PRARI Toolkit of health 
indicators was explained as well as highlighting some of the key elements and areas 
to be monitored. 
 
The following workshop (Ciudad Mitad del Mundo, Ecuador, July 2015) was used to 
debate the difficulties and limitations that the health sectors face in many countries 
in order to be able to resolve the structural problems that perpetuate the 
inequalities and to arrive at an agreement on the conceptual framework which will 
govern the PRARI Toolkit of indicators, the pilot areas to be explored and to begin to 
discuss possible indicators. The final workshop (Buenos Aires, Argentina, October 
2015) provided a space for debating the draft of the PRARI Toolkit and for discussing 
the indicators in more depth.  
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The role of process facilitators was led by UNU-CRIS, in collaboration with other 
members of the PRARI project. In addition to workshops, the PRARI Toolkit is formed 
on the basis of continual communication by different electronic means with the 
team, as well as some interviews with other actors of the region. 
 
CHAPTER 3: CONCEPTUAL FRAMEWORK AND OTHER METHODOLOGICAL 
ASPECTS 
3.1 How are health conditions and health policy indicators defined? 
Health policies have been defined as “courses of action (and inaction) which affect 
the group of institutions, organisations, services and mechanisms of financing of the 
healthcare system" (Buse et al 2012:.6). According to the World Health Organisation 
(WHO), they can also be defined as the decisions, plans and actions which are carried 
out in order to achieve specific health objectives (WHO 2015). 
 
The precise delimitation of health policies is not necessarily simple and it 
complicates the construction of a monitoring system based on indicators. There is a 
tendency to broaden the scope of the health policies, inspired by the literature on 
social determinants of health (Marmot 2005; Puska 2007; WHO 2008). Although, at 
first, a relatively strict interpretation of health policies is opted for, there is full 
awareness of the many transpositions between the health policies and other policy 
areas (Figure 1). It will be incumbent on the users of the indicator system to decide 
when and if the broadening of the indicator PRARI Toolkit in this direction is 
desirable (or not). 
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Figure 1: The overlap of policy areas 
 
 
 
Health policy indicators are numerical/quantitative or qualitative measurements 
which are used to determine whether the objectives of the established health 
targets are being met. When there are objectives for these indicators, they can be 
used as points of reference. These indicators are common to national and sub-
national levels of government (Aller et al, 2015: 1). At these levels, national offices of 
statistics are crucial in the supply of necessary data and information. Monitoring and 
evaluation units within the ministries of health, as well as in other ministries 
including finance and national offices of statistics, play an important role in 
developing these types of useful indicators in the monitoring of changes in policies 
and success in the health field. 
 
On a global level, the World Health Organisation (WHO) has established goals and 
objectives, the realisation of which is measured with clear indicators that are widely 
used by the decision makers, both on an international and national level. Other 
international organisations, such as the United Nations Development Programme 
(UNDP), the Joint United Nations Programme on HIV/AIDS (UNAIDS), the 
United Nations Children's Fund (UNICEF), multilateral development banks, among 
others, have also established indicators to measure the success and failure of health 
policies. 
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The development of indicators at a regional level can appear incipient but it is 
gaining ground. The indicators are frequently provided by the WHO regional offices 
or by regional organisations. The indicators can be focused on either specific 
illnesses, sensitive issues or they can cover the whole system.  
 
3.2 What is meant by monitoring regional policies? 
 
Monitoring in this context refers to the monitoring and evaluation process of the 
application and impact of policies. In particular, it can also mean “a series of relevant 
processes of compiling, processing and distributing information with the aim of 
influencing, checking and/or evaluating the policies of regional integration or in 
order to ensure their application” (De Lombaerde 2008: 284). As De Lombaerde and 
his colleagues state “monitoring has the ability to make the integration processes 
more transparent, involving a greater degree of participation and legitimacy and, 
therefore, making the processes more sustainable” (De Lombaerde, Pietrangeli and 
Weeratunge 2008: 41). In his study on monitoring integration in the Caribbean, 
Girvan suggests that the potential value of surveillance is in decreasing the periods of 
learning cycles and improving the accuracy of problem identification and 
intervention (Girvan 2008: 51). 
 
Successful monitoring must be preceded by the core issues in relation to the object 
that is the subject of the monitoring, the purpose of the monitoring, the modus 
operandi thereof and the agents that participate in the monitoring (Bilal 2009). 
Monitoring must also be motivated by a reason. Some of the possible reasons for the 
monitoring include improving development, evaluation of progress and presentation 
of evidence respecting the capacity of an institution to implement its policies (Bilal 
2009). Monitoring that has clear indicators allows institutions to challenge 
conventional wisdom and assumptions about the success of the regional process (De 
Lombaerde 2008: 284). The modus operandi or methods for monitoring regional 
integration can vary depending on what is being monitored. The means or methods 
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used will largely influence the result of the process. The method will be subject to 
the availability of data, the ability to control and the objective of the process. 
 
3.3 Why are indicators of regional health policies important (useful)? 
 
Monitoring based on indicators of regional health policies, which is the objective of 
this proposal, uses indicators that are implemented by the regional organisations to 
help decision makers monitor the degree of success or failure of the application of 
the health policies and the disciplines which have been agreed on at a regional or 
supranational level. 
 
Estimating the state of health of a population can be very controversial (Byass, 2010; 
Editors, PLoS Medicine, 2010). That is why specific tools, such as indicators can be 
useful in providing a rough map of the reality. Regional indicators of health policies 
are useful for measuring the change of regional health policy, success, stagnation or 
failure and to help domestic policy makers to make course corrections when 
necessary in the implementation process. 
 
They are also indicative of health priorities for regional organisations, whether for 
internal or external interest groups. As for those involved on a domestic level, the 
indicators can be very useful for authorities working in regional organisations in 
policy areas that enter into social determinants of health. Social determinants of 
health include items such as: fair employment, income security, educational 
opportunities, active communities (Lantz and Pritchard, 2010). For external interest 
groups, including international development partners (IDPs), multilateral 
development banks (MDBs), philanthropists, foundations and businesses, 
signposting helps them identify areas where there is room for complementarity. 
 
All of them are related to the fact that the indicators help corroborate performance 
or lack thereof. Yang and Holzer summarise six factors behind the use of 
performance data. These include: system maturity, stakeholder participation, 
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leadership support, support capacity, culture of innovation, and clarity of purpose 
(Yang and Holzer, 2015: 361). From a perspective of historical institutionalism of the 
evolution of Management By Objectives and Results (MBOR) in Denmark, Norway 
and Sweden, it is stated that: "Instead of treating the benefit scheme MBOR as a 
technical ideal, with clear limits it is an institutional option that has various 
institutional configurations and which is affected by path dependence and the 
institutional context" (ibid: 362). 
 
All these elements also refer to the importance of evidence in decision making. 
Anderson et al. (2005: 226) point out that the use of scientific knowledge for policy 
development has grown. While the demand for evidence in public health is at its 
highest point, public health is still below the material base for making decisions 
based on comprehensive evidence (Anderson et al., 2005: 228). It is said that 
evidence based decision making has many benefits (ibid). Regional health indicators 
are an important component in evidence based decision making. Similarly, Boerma 
and colleagues argue that health indicators are essential in guiding the development 
and allocation of resources, but they often lack data (Boerma et al, 2010: 1). For 
them, there is a need to strengthen the way that estimates of health indicators are 
generated (Boerma et al, 2010: 2). The indicators help to summarise a large amount 
of data into useful and viable measures. 
 
Related to this topic, Brownson et al. (2010) argue that to improve health, qualitative 
and quantitative evidence is required, adding that effective health policies and 
resource allocation can improve public health outcomes. They believe that policy 
makers are on the receiving end of data that is often chaotic. Therefore, it is 
essential to have clear tools to assess the burden of disease, set priorities and 
measure progress (ibid). An adage of public health, they note, is: "what gets 
measured gets done" (ibid). 
 
Finally, the development process of indicators that involve those responsible for 
regional health policies, downstream users of the PRARI Toolkit of indicators, is an 
important learning process for all involved. Coburn and Cohen argue that "the 
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lessons from other fields and emerging experiments around the world suggest that 
indicator processes can integrate science, politics, and the community to promote 
greater equity in health" (Corburn and Cohen, 2012: 5). The experience acquired in 
the chapter of PRARI indicator development is corroborative of this pattern of 
mutual learning between policy makers, researchers and NGO participants who have 
actively contributed to the development of the indicators. It is also the result of 
consensus among the different actors who may use this tool to strengthen the 
institutional work of UNASUR and the health policies of countries in the future. 
 
3.4 Into which logical categories can the indicators be arranged? 
 
In our proposal, the system design of indicators follows the logical chain of results; 
subsets of indicators are classified as input, process, output, outcome and impact 
indicators (table 1). This classification is widely used in the literature on the 
development of health indicators (see, for example Boerma, AbouZahr, Evans and 
Evans, 2014: 3 et eq.). 
 
Table 1: Defining input, process, output, outcome and impact indicators 
 
Category Input Process Output Outcome Impact 
Definition They provide a 
follow up on all 
financial and 
physical 
resources 
related to the 
implementation 
of a policy or 
programme. 
They seek to 
assess whether 
the policy is 
being 
implemented as 
planned and 
how well the 
activities are 
carried out. 
They cover all 
the goods and 
services 
generated by the 
use of inputs. 
They report on 
the results of the 
efforts (inputs 
and 
processes/activit
ies) at the 
programme or 
policy level. 
They measure 
the level of 
access to public 
services, the use 
of these services 
and the level of 
user satisfaction. 
They usually 
depend on 
factors beyond 
the control of 
the 
implementing 
body (such as 
the behaviour of 
individuals or 
other factors).  
It measures in 
the long-term, 
the cumulative 
effects of 
policies over 
time on the 
health of the 
population and 
welfare or on 
the larger social 
system. 
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This classification suggests a causal sequence between the different sub-sets of 
indicators. However, some preliminary observations must be made. The first is that, 
even if there is an implicit causal logic between the sub-sets, this does not mean that 
any correlation found in the movement of the indicators of subsequent two 
categories should be interpreted as a demonstration of causality. The logical 
causality plays at the level of subsets, but cannot be traced on the level of individual 
indicators. There are many factors that determine the behaviour of the individual 
indicators in each category. Necessarily, many of these factors are not captured by 
the system of indicators. Demonstrations of cause-effect on the level of indicators, 
requires an additional statistical analysis that goes beyond the scope of a system of 
indicators. 
 
It is also important to note that in this PRARI Toolkit output indicators reflect the 
perspective of the decision makers, while the result indicators adopt a user 
perspective.  
 
The "impact" category (which contains indicators that directly reflect the health 
situation of citizens of a country or region in particular) is clearly both a logical end 
point and a starting point when thinking about regional (and national) health policies 
(Figure 2). 
 
Figure 2: Logical organisation of the indicator system 
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Moreover, even if we think it is useful to adopt such result chain logic, this does not 
necessarily mean that health problems are understood as a system characterised by 
a unilinear causal logic. On the contrary, we are aware that the health system is a 
more complex system with double causalities and other attributes of a complex 
system.  
 
The indicators in each logical category can be sub-classified even further and in 
various ways. One option is to distinguish between "regional" indicators (at the 
UNASUR level) and "national" indicators (Figure 3). This option highlights the nature 
of multi-level governance of modern health policies and keeps the focus on 
interactions between policy levels. While there are different indicators for each of 
these levels, these are often linked. For example, the inputs developed at the level of 
Secretariat which are directed at a specific country, it is natural that they become 
inputs nationwide. 
 
Another option is to organise indicators by priority areas of policy (regional) (Figure 
4), which allows more direct control of policy actions in specific priority policy areas. 
Following this option, it is recommended that a general indicator category is added 
because not all the variables of a relevant policy are specific to a policy priority (or 
specific to the disease) and not all relevant impacts can be attributed to specific lines 
of policy action. Obviously, in the event of partaking in one option or another, this 
can be combined with a secondary sub-classification after the alternative option. In 
addition, when the indicators are codified correctly in a database (in other words, 
one that reflects it belonging to a logical category, its measurement level, its link to a 
policy priority, etc.), they can easily be combined, recombined and presented in 
accordance with the needs of the users. In this document, we are going to opt for an 
organisation in the area of priority policies and they are focused on access to primary 
healthcare (ISAGS 2015) and medicines as pilot cases because this corresponds to 
the concerns of the interested parties as is expressed in the PAR process which leads 
to the development of this System of Indicators (Figure 5). However, this system is 
sufficiently flexible to easily reorganise the indicators. 
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Figure 3: Classification of the indicators by logical categories and measurement 
levels 
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Figure 4: Classification of indicators by logical categories and priority policy areas 
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Figure 5: Classification of indicators by logical categories and identification of the 
pilot priority policy area in UNASUR 
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In terms of the adequate metrics the objective has been to keep the system 
accessible, clear, coherent and sufficiently integrated. For each indicator a 
denominator and a numerator will be established (priority to be assessed). 
 
It is important to note that the actions of the national, regional and supra-regional 
levels are closely related by that which the sequencing of the indicators in those 
levels can also be related. For example, if the UNASUR Health Council agreed on a 
statement regarding access to similar biological medicinal products (generic 
products), which was proposed, negotiated and agreed within the WHO framework, 
this ruling of the WHO can then be used at the level of one of the member countries 
of UNASUR for sanctioning the standard which regulates biological medicinal 
products; reflecting the transfer of regional health policies at different levels.  In 
addition, if other countries outside the region adopt the guidelines agreed by WHO, 
this could have an impact on the region through the importing of generic products 
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produced in countries outside the region which could make progress in this line 
supported in the WHO ruling (product of the work of UNASUR).   
3.5 How to build the “reduction in health inequalities-regional integration” link? 
 
The main added value of the PRARI indicators is that they are responsive to two 
aspects: the reduction of inequalities and regional integration. Many indicators on a 
national and global scale capture vital aspects of health systems and specific 
diseases. To complement these existing national and global efforts, the PRARI 
indicators capture those aspects of the change in regional health policy which are 
distal proxies and close to regional integration and reduction in inequalities. 
 
Regional integration is dealt with here in a flexible way. It incorporates all the cross-
border aspects of the cross-border flows which have links with health policy. 
 
The aspect of reducing the inequalities of the indicators seeks to reflect the 
importance of “people” in the development of indicators in the drawing up of 
regional health policies and their implementation. While some still pay more 
attention solely to national health systems in the broad sense, Frenk argues that 
health is increasingly considered as a wider part of development. Given that a large 
amount of money is allocated to health, more money is not the only requirement for 
progress and the “people” component must be taken more seriously in the area of 
public health (Frenk, 2010: 1; cf: Haines, 2015: 2328).  
 
At the regional level, UNASUR has focused on reducing disparities or inequalities. 
Using this logic, a region with a high level of integration is characterised by the fact 
that the health conditions and its determinants are very similar to one another 
(similarities in terms of mortality rates, life expectancy, access to health services, 
clean drinking water, poverty levels, national inequality levels, etc.). This concept 
proposes regional integration as something that goes beyond the issues of 
geographical closeness and the development of complementarities between 
countries when sharing similar socio-economic and cultural indicators. 
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This is closely related to the topic of Universal Health Coverage (UHC). Many 
countries lack explicit frameworks for monitoring the UHC (Boerma et al, 2014:. 2; cf: 
Kutzin, 2013). What is most required includes a comprehensive system of health 
information, given that the lack of data regarding population needs is an enormous 
problem (Boerma et al, 2014: 4.). Effective coverage in this context means: 
measuring the need, use and quality of the services (ibid), particularly for the most 
vulnerable groups in the respective regions. 
 
The aspect of reducing inequalities can be developed even more through the 
incorporation of additional data for the existing indicators, differentiated by: 
- Demographic groups (gender, by age, among other things); 
- Geographical area (urban, rural); 
- Sub-national regions (departments, provinces);  
- Socio-economic categories (including income categories); and/or 
- Social groups (ethnic groups, religious groups, among others).  
 
The added value of incorporating these sub-indicators will have to be weighed 
against the cost of substantially multiplying the number of indicators in the system. 
 
3.6 How to integrate the SDGs that are related to health? 
 
On 31 December 2015, the Millennium Development Goals (MDGs) will officially 
come to an end and the Sustainable Development Goals (SDGs) will take the lead. 
While the MDGs were focused mainly on poverty and health, the SDGs emphasize 
the environment, human rights and gender equality. 
 
The Millennium Development Goals 
 
There were six main MDGs which were related directly to health. All the goals focus 
on the period 1990 - 2015. The first relevant health goal was the MDG 1 to Eradicate 
Extreme Hunger and Poverty, the aim of which was to halve the proportion of people 
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suffering from hunger. The fourth MDG was aimed at Reducing Infant Mortality 
through a reduction by two thirds of the mortality rate in children under five years 
old. The fifth goal sought to Improve Maternal Health through a reduction by three 
quarters of the maternal mortality rate. The sixth was aimed at Fighting HIV/AIDS, 
malaria and other diseases, by halving the number of cases of HIV/AIDS, malaria and 
other diseases and starting to reverse their spread. The seventh goal was to Ensure 
Environmental Sustainability. The relevant health goal involved halving the 
proportion of people without sustainable access to the supply of clean drinking 
water and to basic sanitation services. Lastly, the eighth relevant health goal in the 
MDGs was to Develop a Global Partnership for Development. The relevant health 
goal would refer to cooperation with pharmaceutical companies with the aim of 
providing access to affordable essential drugs in developing countries. 
 
Health occupied an important position in the MDGs, transmitting the idea that 
health is essential for development. Six of the eight goals concerned were related 
directly or indirectly to health and eight out of 21 goals were related to health. On 
the other hand, these objectives were established in terms of a decrease in the 
percentages. The main criticism was the omission of issues that featured in the 
Millennium Declaration and the absence of political consultation in the whole 
process (Alleyne, Beaglehole and Bonita 2015). 
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The Sustainable Development Goals (SDGs) 
 
The Post-2015 Agenda aims to deal with the challenges that outlast the MDGs. The 
process of forming the SDGs is politically inclusive and consultative. In turn, it can 
define a more general set of goals. There are 17 objectives and 189 goals, doubling 
the objectives of the MDG and increasing fivefold the aims of MDGs. Political 
consensus has been achieved but the aims are characterised as general and vague. 
There is also a relatively small set of priorities directly linked to health. There is a 
specifically relevant health objective (SDG3), which includes nine goals and nine 
additional aims arising from other objectives relating to health. 
 
The third SDG, “To ensure a healthy life and promote well-being for everyone at any 
age”, highlights the call for solidarity: “No-one should be left behind”. The nine aims 
of this goal cover a variety of already familiar topics and other new ones and they 
strive to achieve that which is pre-established for the deadline of 2030. These are 
given in Table 2. 
 
There is a desire to speed up the progress regarding the reduction of newborn, 
infant and preventable maternal mortality as well as concerns for adolescents. A 
similarly ambitious objective is to fight and end malaria, HIV/AIDS, tuberculosis, 
hepatitis, Ebola and other contagious diseases and epidemics. More recent goals 
include improving mental health, wellbeing and non-communicable diseases such as 
behavioural, development and neurological disorders. Preventing smoking, 
harmful alcohol consumption and substance abuse, family planning and education, 
traffic accidents as well as environmental factors and their relation to health are all 
supplementary goals to be taken into account. Lastly, the most discussed aim of the 
SDG 3 is the call for universal health coverage under the adage that “no-one should 
be left behind” and a focus on vulnerable groups. 
 
There are nine additional SDGs whose goals are important for health. The second 
SDG aims to “End hunger, achieve food security and improved nutrition and promote 
sustainable agriculture”, guaranteeing that the poor and vulnerable gain access to 
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healthy, nutritious and sufficient food, putting an end to all forms of malnutrition. 
SDG 5, which focuses on gender equality, has a clause to guarantee universal access 
to sexual and reproductive health and to reproductive rights. The sixth SDG seeks to 
“Ensure the availability and sustainable management of water and sanitation for all”. 
The goals associated with this strive to achieve universal and equal access to a supply 
of clean and safe drinking water, at a reasonable price, and access to adequate and 
fair hygiene and sanitation services, with particular attention paid to women and 
girls. SDG 7, whose emphasis is on energy, could also increase the services that 
hospitals and community health centres provide. SDG 9 focuses on resistant 
infrastructure, which could be of considerable benefit for hospitals and health 
centres. The eleventh SDG focuses on human settlements and safe and healthy 
homes. SDG 12, goal 13, aims to achieve correct and complete management of 
chemicals and waste with the aim of protecting human health and the environment. 
Lastly, the “Peace and Stability” SDG (16) can have a positive impact on the mental 
and physical health of communities (OWG 2015). 
 
The measuring of the attainment of the SDGs and other regional policies will give 
countries and the Secretariat of the UNASUR the basis for carrying out a monitoring 
of the coherence of these policies with these objectives established globally, in order 
to quickly identify the countries that require support to achieve those objectives and 
to coordinate efforts in the measuring that is already taking place. 
 
The list of sub-goals of the SDGs which are closely related to health are given in table 
2. Figure 6 shows that the SDGs related to health can be classified in accordance with 
logical categories. The complete list of health-related SDGs is given in annex 2. 
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Table 2: Sustainable Development Goals pertaining to health 
 
 
Sustainable Development Objective specific to health 
Goal Objectives 
 
 
 
 
3.  Ensure healthy lives and promote well-being 
for all at all ages 
1) Reduce the global maternal mortality ratio to 
less than 70 per 100,000 live births 
2) End preventable deaths of newborns and 
under-five children 
3) End the epidemics of AIDS, tuberculosis, 
malaria, and neglected tropical diseases and 
combat hepatitis, water-borne diseases, and 
other communicable diseases 
4) Reduce by one-third pre-mature mortality 
from non-communicable diseases (NCDs) 
through prevention and treatment, and 
promote mental health and wellbeing 
5) Strengthen prevention and treatment of 
substance abuse, including narcotic drug abuse 
and harmful use of alcohol. 
6) Halve global deaths and injuries from road 
traffic accidents (by 2020) 
7) Ensure universal access to sexual and 
reproductive health care services, including for 
family planning, information and education, and 
the integration of reproductive health into 
national strategies and programmes 
8) Achieve Universal Health Coverage (UHC). 
9) Substantially reduce the number of deaths 
and illnesses from hazardous chemicals and air, 
water, and soil contamination 
 
 
Source: Open Working Group (2015). Open Working Group proposal for Sustainable Development 
Goals. Available at:  https://sustainabledevelopment.un.org/focussdgs.html 
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Figure 6: Integration of the health-related Sustainable Development Goals in the PRARI 
Toolkit 
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3.7 How to select individual indicators? 
 
The potential range and number of health indicators is huge (Larson and Mercer 
2004: 1199). Faced with this reality and due to the existence of limited resources it is 
recommended and considered advisable to select some areas which can be correctly 
monitored (ibid). Larson and Mercer highlight that the characteristics of a good 
system of health indicators include: being defined (applicable internationally), being 
valid, (measures what it claims, replicable and interpretable), feasible (particularly in 
the collection of data), and useful (ibid). They suggest that particularly in contexts 
where resources are limited, the developers of indicators should focus on a small 
number of health indicators that measure areas of high priority. They should use 
more efficient sampling frames and make use of standard international definitions 
(Larson and Mercer 2004: 1200). 
 
The indicators in the PRARI Toolkit were selected based on regional priorities and 
priorities of the Member States (including non-governmental bodies); their inclusion 
in international declarations to which Member States are subscribed; whether the 
indicator is being used by countries in the monitoring of national plans and 
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programmes; whether it is based on existing projects; and if it fulfils the original aims 
of this exercise. 
 
In addition, the indicators were selected by following the “SMART” criteria. This 
means that the indicators are: Specific (focused and clear); Measurable (quantifiable 
and capable of reflecting change); Accessible (reasonable in their scope and 
achievable within a set timeframe); Relevant (appropriate to the performance 
review); and with a set/traceable duration (progress can be traced by chronological 
order) (MLE, 2014). 
 
Other considerations used in the selection of an indicator were (Parrish, 2010): 
 The indicator is valid and reliable 
 The indicator can be understood by the people who must make decisions 
 The indicator galvanises action 
 The action can improve the indicator 
 The indicator measurement reflects over time the effect of the action - 
ceteris paribus (all other things being equal) 
 The indicator measurement is feasible 
 The data for the indicator is available for the different geographical levels and 
population sub-groups. 
 The indicator is sensitive to changes in other social areas (socio-economic, 
environmental or public policies) 
 
3.8 What are the sources of the specific indicators? 
 
National indicators meet health priorities fixed by governments of the Member 
countries, large international health organisations and other institutions. Regional 
indicators were selected according to the priorities that UNASUR Health have fixed in 
their working documents and agreements. Following the guidelines established in 
those documents is crucial for avoiding duplication of efforts and determining the 
state of health of populations (Brownson et al, 2009: 1576). 
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Furthermore, the indicators were selected and discussed during the PRARI 
workshops and during the indicator development meetings mentioned beforehand. 
Through these meetings the facilitators had the opportunity to directly listen and 
cooperate with those who will be the end users. 
 
In Annex 1, it is indicated whether the statistical data for measuring the indicators is 
available and, if so, what are the statistical sources.3 
It should be taken into account that a distinction must be made between the 
measurement level and the production site (and publication) of the indicators. 
Theoretically, various combinations of measurement levels are possible (figure 7). 
 
Figure 7: Measurement level versus production site of data 
 
 
                     Source 
 
Measurement 
Level 
National 
Regional (and 
extra-regional) 
National 
  
Regional (and 
extra-regional) 
  
 
 
3.9 What is the baseline for the indicators? 
 
Taking into account that UNASUR is a relatively new organisation that has extended 
its participation in the last five years; we use 2010 as a baseline for indicators, which 
is the start date of the first UNASUR Five-Year Health Plan (2010-2015). This will 
allow us to collect more complete information regarding the changes that have 
taken place in the region in the last five years, as well as the way in which ISAGS and 
                                                        
3 Regarding the production of statistical data on health in South America within a context of 
multi-level governance, see Amaya et al. (2015). 
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UNASUR-Health in general, have matured as institutions of regional integration of 
health. 
 
It is expected that the data from these indicators will be collected annually, except in 
circumstances where the specific indicator is substituted less frequently. This 
frequency will provide a reasonable period of time for the complete 
institutionalisation of the PRARI Toolkit, which is a challenge for any system 
monitoring health (Oliver, 2010). 
 
The collection of these indicators requires a degree of commitment on the part of 
the country and regional officials. However, it must be taken into account that many 
of these indicators are already being collected either as basic indicators of health 
which are reported to the WHO or as part of other monitoring systems. This means 
that the reporting burden will be less and its complementarity with various new 
indicators will increase the wealth of information and allow for a better 
interpretation of the results. 
 
Lastly, this monitoring system is being developed while the five-year plan is being 
discussed. An important objective of this monitoring system is to both support this 
discussion process and provide a practical tool for evaluating the contribution of 
UNASUR Health in the access to primary healthcare and medicines in its new phase 
of work. 
 
3.10 Limitations 
 
Firstly, the large number of indicators included could be symptomatic of the scope of 
priorities and issues that the region face. The multiplicity of indicators makes the 
difficulties in reporting that national officials may have worse. Some maintain that 
the benefits derived from the information are not always apparent (Hibbard, 2008: 
160). The development of indicators that are applicable to many countries of a 
diverse region can be a complex task and it also involves making key choices 
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(Boerma, AbouZahr, Evans and Evans, 2014). In any case, what we have wanted to 
highlight is the relevance of the indicators for UNASUR. The fact that the information 
required is available for regional health policy-makers to substantially support 
specific regional indicators helps mitigate this apparent challenge.  
 
Chapter 4: The Indicators 
 
This PRARI Toolkit is composed of 151 indicators. The baseline suggested for the 
Toolkit is the year 2010, the start date of the Five-Year Plan of UNASUR Health 
(2010-2015). The use of this baseline will provide a level of comparison against which 
they will be able to confirm trends and/or evaluate the success of regional policies. 
We suggest as an annual collection of data for this PRARI Toolkit to monitor the 
scope of the policies and readjust interventions.  
 
In this proposal, the SDGs are partially dealt with in order to have a list of 
manageable indicators. However, they can readily be included in their entirety. The 
total list of SDGs related to health is provided in Annex 1.  
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5.1 General indicators 
 
INPUT 
 
PROCESS 
 
OUTPUT 
 
OUTCOME 
 
IMPACT 
General health indicators 
 Percentage of total 
current expenditure on 
health (% of GDP) 
 
 Expenditure on 
continuous training 
programmes for 
primary and secondary 
healthcare 
 
 Out-of-pocket health 
expenditure (% of 
current health 
expenditure) 
 
SDG 3c: 
Substantially increase 
financing for health and 
recruitment, 
development, training 
and retention of human 
resources in health: 
 
  Number of training 
programmes for health 
workers (per 1000 
workers)  
 
 Number of continuous 
healthcare training   
programmes 
  Density of hospital 
beds 
 
 Hospital beds per 
1000 inhabitants 
(urban and rural 
distribution) 
 
 Distribution of 
primary and 
secondary healthcare 
establishments in 
urban areas 
 
 Distribution of 
primary and 
secondary healthcare 
establishments in 
rural areas 
 
 Distribution of health 
workers in urban 
areas 
  Proportion of the 
population who have 
to travel for more 
than 1 hour to get to 
the primary level 
healthcare centre 
 
 Use of services 
 
 Access to health 
services 
 
SDG 3, sub-goal 8: 
 Portion of the 
population 
protected against 
impoverishment 
due to out-of-
pocket health 
expenditure  
 
 Portion of the 
homes protected 
  Maternal and infant 
mortality rate 
 
 Mortality rate due to 
chronic illnesses 
 
 Mortality rate from 
infectious diseases 
 
 GINI index4 
 
SDG 3: 
 Life expectancy at 
birth 
 
    
    
    
                                                        
4 Possibly disaggregated by urban and rural population  
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 Variance percentage 
of expenditure on 
human resources in 
health 
 
 
 Distribution of health 
workers in rural areas 
 
 Number of health 
worker graduates 
 
 Number of 
professionals who 
have completed 
continuous training 
programmes in 
healthcare 
 
 Density of health 
workers in rural areas 
 
 Density of health 
workers in urban 
areas 
against catastrophic 
expenditure caused 
by out-of-pocket 
health expenditure 
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5.2 Indicators regarding access to primary healthcare (PHC) 
 
 
INPUT 
 
PROCESS 
 
OUTPUT 
 
OUTCOME 
 
IMPACT 
Primary healthcare (PHC) 
National level 
 Existence of human 
resources policies in 
PHC 
 
 
 Existence of adequate 
HR distribution policies 
in PHC 
 
 Expenditure on PHC 
infrastructure and 
human resources 
 
 Percentage of the 
budget allocated to 
PHC 
 
 Expenditure on 
continuous training in 
PHC 
  Proper 
implementation of 
policies for the 
promotion of human 
resources in PHC 
 
 Proper 
implementation of 
policies for the proper 
distribution of human 
resources in PHC  
 
 Number of PHC 
training institutions 
 
 Number of continuous 
education PHC 
programmes 
 
 Number of health 
promotion 
  Employee density in 
PHC  
 
 Density of PHC staff in 
rural areas (per 1000 
inhabitants) 
 
 Density of primary 
healthcare units  
 
 Number of primary 
healthcare units 
 
 Number of PHC 
graduates 
 
 Distribution of PHC 
workers 
 
 Number of 
  Percentage of homes 
whose members have 
to travel more than 1 
hour to get to the 
nearest primary 
healthcare centre 
 
 Percentage of first level 
PHC consultations 
 
 Percentage of first level 
PHC consultations 
 
 Immunisation coverage 
for each vaccine in the 
national schedule 
 
 
 Percentage of diabetics 
in the Hbc<6 control 
  Percentage of 
households with 
affordable primary 
healthcare coverage    
 
 Prevalence of anaemia 
in children aged 6-59 
months  
 
 Percentage of children 
under 5 who are 
malnourished 
(moderate and severe) 
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 Percentage of total 
current health 
expenditure (% of 
GDP) intended for PHC 
 
 Percentage of the PHC 
budget to promote 
health 
 programmes  professionals that have 
completed continuous 
training programmes 
in PHC 
 
 Percentage of children 
under 5 years old that 
receive 
accompaniment 
(healthy children 
check, growth check) 
 
 Coverage of adult 
patients with 
diabetes/hypertension 
 
 Number of leaflets, 
advertisements or 
other means of 
dissemination to 
promote healthy 
lifestyles. 
 
 Coverage for the 
promotion of the 
health of people of all 
ages 
 
SDG 3, sub-goal 8: 
 Percentage of births 
carried out by qualified 
healthcare staff 
 
 programme 
 
 Percentage of patients 
with hypertension in 
the diastolic <90 
control programme 
 
SDG 3, sub-goal 8: 
 Coverage of antenatal 
care (+ 4 visits) 
 Immunisation 
coverage (full or DTP3) 
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At regional level 
 Expenditure of 
UNASUR on training to 
carry out the PHC 
strategy. 
 
 Expenditure in respect 
of PHC coordination 
and meetings 
 
 Number of 
Resolutions/regional 
agreements in favour 
of accessing PHC 
 
 Total expenditure of 
UNASUR in PHC 
  Number of training 
sessions to train PHC 
experts 
 
 Number of experts 
bringing proposals of 
UNASUR to 
multilateral spaces. 
 
 Number of 
meetings/regional 
events to discuss 
actions  
 
 Number of countries 
participating in 
coordination meetings 
regarding access to 
PHC 
 
 Proper 
implementation of 
PHC policies from 
UNASUR agreements  
 
 Number of regional 
working groups to 
discuss actions to 
improve access to PHC 
 
  Number of proposals 
made in favour of 
global access to PHC 
 
 Number of trained 
experts that replicate 
the learning5 
 
 Number of experts 
trained in the 
implementation of PHC 
 
 Number of countries 
with the highest rate of 
distribution of PHC 
services 
 
 Number of countries 
with improved PHC 
strategies 
 
 Number of partnerships 
with other agencies on 
issues of access to PHC 
  Number of common 
positions on PHC from 
UNASUR in multilateral 
spaces 
 
 Average rate of access 
to PHC among member 
countries 
  
    
    
    
                                                        
5 These can be used as inputs of indicators at national level 
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 Number of acts, 
agreements from 
coordination meetings 
on access to PHC 
 
 Number of meetings 
with other regional 
bodies on the issue of 
access to PHC 
 
 Number of projects 
with other bodies 
regarding access to 
PHC 
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5.3 Indicators regarding access to medicines 
 
INPUT 
 
PROCESS 
 
OUTPUT 
 
OUTCOME 
 
IMPACT 
Access to medicines 
National level 
 Public investment in 
pharmaceutical 
education 
 
 Human resources 
policies for 
pharmaceutical 
resources  
 
 Existence of proper HR 
distribution policies in 
pharmaceutical 
resources 
 
 Existence of 
promotion rules for 
the use of generics  
 
 Existence of national 
production promotion 
  Amount of public and 
private 
pharmaceutical 
training institutions. 
 
 Proper 
implementation of the 
policies for the 
promotion of total 
pharmaceutical 
human resources 
 
 Proper 
implementation of 
policies for the proper 
distribution of total 
pharmaceutical 
human resources 
 
 Proper 
implementation of 
  Distribution of 
pharmacy staff 
graduates in rural and 
urban areas 
 
 Density of 
pharmacists  
 
 Total number of 
pharmacists in the 
country 
 
 Density of 
pharmaceutical 
workers in rural areas 
x 1000 inhabitants 
 
 Percentage of 
national medication 
production 
  Annual variation of the 
(retail) market price 
index 
 
 Amount of medicines 
out of stock 
 
 Free coverage of 
HIV/AIDS medicines 
 
 Free basic and essential 
medication coverage 
 
 Relationship between 
domestic and 
international prices 
 
 Percentage of 
medicines imported 
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rules 
 
 Existence of a list of 
medicines that are 
guaranteed by 
governments 
 
 Does the list include 
high cost medicines? 
 
 Is financing in the 
public system 
complete? 
 
 Is financing in the 
private system 
complete? 
 
 Current expenditure 
for imports of 
medicines in relation 
to total imports 
 
 Are the regional 
(MERCOSUR/UNASUR) 
regulations regarding 
joint purchases 
applied in the country? 
 rules to promote the 
use of generic 
medicines 
 
 Existence of a public-
private alliance to 
develop different 
outputs: 
 
 Existence of periodic 
updating: is the list of 
specialised 
medications updated 
periodically? 
 
 Proper 
implementation of 
policies from 
agreements made by 
UNASUR on access to 
medicines 
 
  
 Existence of good 
practices for the 
manufacture of 
medicines 
 
 Existence of 
pharmacovigilance 
practices 
 
 Percentage of 
medications produced 
in the country 
 
 How many joint 
purchases of 
medications took 
place with other 
countries? 
 
 
  Percentage of export of 
medications 
 
SDG 3, sub-goal 8: 
Universal health coverage 
including protection 
against financial risks, 
access to basic and 
quality healthcare 
services and access to 
medicines and safe, 
effective and 
affordable vaccines for 
all: 
 
  Percentage of people 
with health coverage 
including medications 
and vaccines   
 
 Existence of subsidies 
for medications for 
low-income people 
 
 
 
 
SDG 3b: 
Research and production 
of vaccines and 
medicines and the 
supply of basic 
vaccines, in 
accordance with the 
Doha Declaration, 
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which establishes the 
right of the developing 
countries to maximum 
use of the provisions 
of the TRIPS 
agreement with 
regards to the 
flexibility to protect 
public health and 
generally provide 
access to medicines for 
everyone: 
 
 Amount of compulsory 
licences granted 
 
 Amount of national 
pharmaceutical patents 
 
 Percentage of 
participation of the 
domestic industry in 
domestic sales of 
medications 
 
SDG 3b: 
 
 Percentage of the 
population with access 
to basic medicines and 
external, affordable 
and sustainable 
supplies 
 
SDG 3, Sub-goal 3: 
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 Coverage rates for 
tuberculosis treatment 
 
 Coverage rates for 
HIV/AIDS treatment 
 
 Treatment rate for 
diabetes 
 
 Coverage/treatment 
rate for hypertension 
 
SDG 3, sub-goal 8: 
 
 Percentage of under-
aged children with a 
complete vaccination 
regime   
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At regional level 
 UNASUR total 
expenditure allocated 
for accessing 
medicines 
 
 Training expenditure 
 
 UNASUR expenditure 
on meetings and 
coordination regarding 
access to medicines 
 
 Number of 
Rulings/regional 
agreements in favour 
of accessing medicines 
  Number of experts 
leading UNASUR 
proposals in 
multilateral spaces6 
 
 Number of regional 
meetings/events to 
discuss actions to 
improve access to 
medications. 
 
 Number of countries 
that have participated 
in coordination 
meetings on access to 
medications 
 
 Proper regional 
implementation of 
policies based on 
agreements taken in 
UNASUR regarding 
access to medicines  
 
 Number of regional 
working groups to 
discuss actions to 
improve access to 
medications 
 
  Number of proposals 
made in favour of 
accessing medicines 
globally 
 
 Number of experts 
trained in the field of 
access to medications 
 
 Number of resolution 
projects regarding 
medicines approved by 
the Health Council or 
Ambassadors. 
 
 Number of projects 
with other agencies on 
access to medications 
for the region 
  Number of common 
positions of UNASUR 
on access to 
medications approved 
in multilateral spaces 
 
 Average rate of access 
to medications 
between member 
countries 
  
    
    
    
                                                        
6 To be measured from 2010 
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 Number of acts, 
agreements from 
coordination meetings 
on access to 
medications 
 
 Number of meetings 
of other bodies 
regarding access to 
medicines in which 
UNASUR or other 
member states have 
participated. 
 
 Number of alliances 
with other bodies 
regarding access to 
medicines 
Medicine price bank 
 Total expenditure of 
the project for the 
creation of a South 
American bank of 
prices 
  Number of meetings 
between the countries 
for the review and 
implementation of the 
project 
 
 Number of countries 
using the list from the 
medication price 
database 
 
 Proper 
implementation of the 
    Percentage of products 
experiencing a 
reduction in the 
disparities of prices 
between UNASUR 
member countries. 
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bank of medicine 
prices 
 
 Amount of countries 
producing at least 40% 
of the medicines listed 
Joint purchase of medicines 
 Subscription/signing of 
the medicine 
acquisition agreement 
through the 
PAHO/WHO strategic 
fund 
  Number of medicines 
negotiated between 
the member states of 
UNASUR 
 
 Number of 
preparatory meetings 
 
 Proper 
implementation of the 
joint purchase of 
medicines in the 
countries 
 
 Number of countries 
subscribed 
  Amount of medicines 
acquired through the 
PHO/WHO strategic 
fund 
 
 Total amount of 
medicines acquired 
through the 
PHO/WHO strategic 
fund 
  Percentage of 
population with 
coverage of medicines 
purchased under this 
framework due to 
illness 
 
 Regional reduction in 
medicine acquisition 
price 
 
 Reduction of the 
average price 
compared to the 
proper international 
average 
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Chapter 5: Implementation of the PRARI Toolkit 
 
When reviewing other experiences of monitoring systems training based on 
indicators in other regions, we have found that the governance aspects are as 
important as the technical aspects of the indicators themselves (De Lombaerde et 
al., 2008, 2010).  In this sense, it is important that a body or individual takes the lead 
in spreading and implementing the PRARI Toolkit. This will make its long-term 
sustainability easier, as well as its acceptance by the decision makers (Navarro et al., 
2006).  
 
The indicators will be relevant mainly for the regional decision makers. In addition to 
other entities that are interested in studying the implementation process of regional 
policies in South America. In order to implement this system in an effective way, 
mechanisms and resources will have to be established to collect data from the 
member countries, to store that data and analyse it in order to come to proper 
conclusions to support the training or motivate changes in the existing policies. 
Regarding data collection, the countries have already collected some of the 
indicators, so there is no need to make an additional effort to collect this data. The 
indicator system also considers the SDGs that have been used by UNASUR, so it will 
contribute to providing a regional overview of the goals accomplished.  
 
The PRARI Toolkit was formulated in order to be a flexible system that can be shaped 
and adjusted over time in accordance with needs and circumstances. In this way, it 
will be possible to take some key indicators from the PRARI Toolkit in order to create 
separate analyses. In addition, considering that the indicators included now in the 
PRARI Toolkit comprise two pilot areas to be explored, the conceptual framework 
can be applied to other areas of health such as health monitoring or access to 
universal systems, among others.  
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Annex 1. Breakdown of the indicators 
 
General health indicators 
 
Input: 
 
1. Percentage of total current health expenditure (% of GDP) 
Numerator: The total of public and private health expenditure, x 100. This covers the 
provision of health services (preventive and curative), family planning, nutrition 
activities and emergency assistance allocated for health but does not include the 
provision of water and sanitation. 
 
Denominator: National GDP 
 
Period of measurement: Annually 
 
Source: National health accounts, documents and reports in the public domain. 
 
Explanation: Determining the contribution of the Government and the private sector 
to health expenditure in relation to the country’s output. 
 
2. Spending on continuing training programmes for primary and secondary 
healthcare 
Numerator: Budget for continuing training programmes for primary and secondary 
healthcare x 100 
 
Denominator: Current expenditure budget 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national budget plan 
 
Explanation: Determining investment in continuous training in primary and 
secondary healthcare 
 
3. Out-of-pocket health expenditure (% of current health expenditure) 
Numerator: Out-of-pocket expenditure x 100 
 
Denominator: Current health expenditure 
 
Period of measurement: Annually 
 
Source: Administrative information system, national accounts 
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Explanation: This indicator measures the percentage of the population at risk of 
impoverishment 
 
4. Variance percentage of expenditure on human resources in health  
SDG 3c: to substantially increase funding for health and the recruitment, 
development and training and retention of healthcare human resources 
 
Numerator: Difference between the human resources health expenditure for the 
year/period of study and the previous year/period   
 
Denominator: National GDP  
 
Period of measurement: Annually 
 
Source: National health accounts, documents and reports in the public domain 
 
Explanation: Determining the recruitment effort in the health sector 
 
Process: 
 
5. Number of training programmes for health workers (per 1000 workers) 
Numerator: Number of training programmes for health workers 
 
Denominator: 1000 workers 
 
Period of measurement: Annually 
 
Source: Information systems at healthcare training centres, the Ministry of Health’s 
administrative information systems 
 
Explanation: Determining the availability of training programmes in healthcare 
 
 
6. Number of continuing training healthcare programmes 
Numerator: Number of continuing training programmes in healthcare 
 
Denominator: N/A 
 
Period of measurement: Every two years 
 
Source: Administrative information systems, information systems in healthcare 
training centres 
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Explanation: Determining the public effort in continuous training programmes in 
healthcare. 
 
Output: 
 
7. Density of hospital beds 
Numerator: No. of hospital beds (hospital beds include inpatient beds in public, 
private, Social Security, general and specialised hospitals and rehabilitation centres)  
 
Denominator: 1,000 inhabitants 
 
Period of measurement: Annually 
 
Source: Systematic administrative records from public and private hospitals 
Explanation: Determining the sustainability of the ratio of hospital beds per 1,000 
people 
 
8.  Hospital beds per 1000 inhabitants (urban and rural distribution) 
Numerator1: No. of hospital beds in the urban area 
 
Numerator2: No. of hospital beds in the rural area 
 
Denominator: 1,000 inhabitants  
 
Period of measurement: Annually 
 
Source: Systematic administrative records from public and private hospitals 
 
Explanation: Hospital beds are used to indicate the availability of hospital services.  
 
9. Distribution of primary and secondary healthcare establishments in urban 
areas   
Numerator: No. of primary and secondary care facilities 
 
Denominator: 10,000 inhabitants 
 
Period of measurement: Annually 
 
Source: Administrative information systems 
 
Explanation: Determining the availability of primary and secondary healthcare 
centres. 
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10. Distribution of primary and secondary healthcare establishments in rural 
areas 
  
Numerator: No. of primary and secondary healthcare establishments in rural areas x 
100 
 
Denominator: Population of 10,000 inhabitants 
  
Period of measurement: Annually 
  
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of and access to healthcare 
 
11. Distribution of health workers in urban areas 
Numerator: No. of employees in the health sector in urban areas x 100 
 
Denominator: Population of 10,000 inhabitants 
  
Period of measurement: Annually 
  
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of and access to health workers in urban 
areas 
 
12. Distribution of health workers in rural areas 
Numerator: No. of employees in the health sector in rural areas x 100 
 
Denominator: Population of 10,000 inhabitants 
  
Period of measurement: Annually 
  
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of and access to health workers in rural 
areas 
 
13. Number of graduate health workers 
Numerator: No. of students who graduated from their studies in the same year of 
studies x 100 
 
Denominator: No. of healthcare workers who entered that year of studies 
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Period of measurement: Annually 
 
Source: Records from healthcare centres, university records 
 
Explanation: Determining the proportion of graduates among all health workers 
 
14. Number of professionals who have completed continuous training 
programmes in healthcare 
Numerator: No. of professionals who have completed continuous training 
programmes in healthcare 
 
Denominator: No. of health professionals 
 
Period of measurement: Annually 
 
Source: Training centres, administrative information systems, continuing education 
programmes, no. of graduates 
 
Explanation: Determining the labour force in terms of quality of continuous training  
 
15. Density of health workers in rural areas  
Numerator: No. of health workers x 100 
 
Denominator: Population of 1,000 inhabitants 
 
Period of measurement: Annually 
 
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of healthcare human resources in rural 
areas 
 
16. Density of health workers in urban areas 
Numerator: Total number of health workers in urban areas (active labour force) x 
100 
 
Denominator: Population of 1,000 inhabitants 
 
Period of measurement: 1-2 years 
Source: Administrative reporting system, population census, health establishments’ 
evaluations 
 
Explanation: Determining the availability of healthcare human resources in urban 
areas. 
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Outcome: 
 
17. Proportion of the population who have to travel for more than 1 hour to get 
to the primary level healthcare centre 
Numerator: No. of households traveling for more than 1 hour to get to the nearest 
public health centre x 100 
 
Denominator: Total number of households 
 
Period of measurement: Annually 
 
Source: Sanitary facilities database, geospatial modelling and analysis 
 
Explanation: Determining physical access to health 
 
18. Use of services 
Numerator: Total number of visits to the outpatient clinics service per year 
 
Denominator: Total population 
 
Period of measurement: Annually 
 
Source: Population-based surveys, systematic administrative information systems 
 
Explanation: Determining the degree of access, availability and utilisation of 
outpatient clinics 
 
19. Access to health services 
Numerator: Number of facilities in the public and private sectors. 
 
Denominator: Total population. 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national surveys, sanitary facilities 
database, geospatial modelling and analysis 
 
Explanation: Determination of geographical and social accessibility 
 
20. SDG 3, sub-goal 8: 
a. Fraction of the population protected from impoverishment due to out-of-pocket 
health expenditure 
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Numerator: Number of persons protected against impoverishment due to out-of-
pocket health expenditure (where health expenditure does not prevent other 
expenses) 
 
Denominator: Total population that incurs out-of-pocket health expenditure 
 
Period of measurement: Annually 
 
Source: Population-based health surveys, administrative information systems 
 
Explanation: Fraction of the population protected against impoverishment resulting 
from direct health expenditure, made up of two types of households: families which, 
due to their consumption, are already below the poverty line and families that incur 
direct healthcare costs that plunge them even further into extreme poverty; families 
who, because of their direct health expenditures, are pushed into poverty. 
 
b. Fraction of households protected against catastrophic expenses caused by out-of-
pocket health expenditure 
 
Numerator: Number of households protected against catastrophic expenses caused 
by out-of-pocket expenditure 
 
Denominator: Total households that use out-of-pocket health expenditure 
 
Period of measurement: Annually 
 
Source: Population-based health surveys, administrative information systems 
 
Explanation: fraction of households protected against catastrophic expenses derived 
from direct health expenditure. A household with catastrophic health expenditure is 
defined as anyone household devoting more than 30% of its capacity to pay to the 
financing of the health of its members. 
 
Impact: 
 
21. Maternal and infant mortality rate 
a. Maternal mortality rate 
 
Numerator: No. of maternal deaths 
 
Denominator: Live births. 
 
Period of measurement: 1-5 years 
 
Source: Civil records 
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Explanation: The annual number of deaths of women for any reason related to or 
aggravated by pregnancy or its management (excluding accidental or incidental 
causes) during pregnancy and childbirth, or within 42 days of the termination of 
pregnancy, irrespective of the duration and site of the pregnancy, expressed per 
100,000 live births, for a specified period of time. 
 
b. Infant mortality rate 
 
Numerator: No. of deaths of children under one year of age 
 
Denominator: 1,000 children less than a year old   
 
Period of measurement: 1-5 years 
 
Source: Civil records 
 
Explanation: Determining the probability of dying during the first year of life in the 
living conditions during that year. 
 
22. Mortality rate due to chronic diseases 
Numerator: No. of deaths of people suffering from a chronic disease  
 
Denominator: No. of years of exposure to the risk of death 
 
Period of measurement: 1-5 years 
 
Source: Civil records, health centre records 
 
Explanation: Determining the probability of a person dying of a chronic disease  
 
23. Mortality rate from infectious diseases 
Numerator: No. of deaths of persons suffering from an infectious disease  
Denominator: No. of years of exposure to the risk of death 
 
Period of measurement: 1-5 years 
 
Source: Civil records, health centre records 
 
Explanation: Determining the probability that a person dies of an infectious disease  
 
24. GINI index7 
Numerator: the area between the Lorenz distribution curve and the (perfect) 
                                                        
7 Possibly disaggregated by urban and rural population 
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uniform distribution line 
 
Denominator: the area under the uniform distribution line 
 
Period of measurement: Annually 
 
Source: Administrative information systems, population-based surveys 
 
Explanation: Determining how much income distribution deviates from the perfect 
uniform distribution. 
 
25. SDG 3: Life expectancy at birth 
Method: The life table method 
 
Period of measurement: Annually 
 
Source: Civil records 
 
Explanation: The average number of years that a newborn child can expect to live if 
he or she were to go through life exposed to mortality rates by gender and age 
prevailing at the time of his or her birth, for a specific year, in a given country, 
territory, or geographic area. 
 
Primary health care: national level 
 
Input: 
 
26. Existence of human resources policies in PHC 
YES/NO 
 
Period of measurement: Annually 
 
Source: Administrative and legislative information system 
 
Explanation: Determining the political effort in PHC resources in terms of human 
resources 
 
27. Existence of adequate distribution of human resources policies in PHC YES/NO 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Administrative and legislative information system 
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Explanation: Determining the political effort for a proper distribution of human 
resources in PHC 
 
28. Spending on PHC infrastructure and human resources 
Numerator: Budget exercised in PHC infrastructure and human resources x 100 
 
Denominator: Current expenditure budget 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national budget plan 
 
Explanation: Determining the level of investment in PHC infrastructure and human 
resources 
 
29. Percentage of the budget allocated to PHC  
Numerator: Budget allocated to PHC x 100 
Denominator: General public budget 
Period of measurement: Annually 
Source: Administrative information systems, national budget plan 
Explanation: Determining the investment for PHC systems 
30. Expenditure on continuing PHC training 
Numerator: Budget for continuing PHC training programmes x 100 
 
Denominator: Current expenditure budget 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national budget plan 
 
Explanation: Determining investment in continuous healthcare training 
 
31. Percentage of total current health expenditure (% of GDP) intended for PHC 
Numerator: Budget for PHC x 100 
 
Denominator: Budget for total current health expenditure 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national budget plan 
 
Explanation: Determining investment in PHC systems 
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32. Percentage of PHC budget for health promotion 
Numerator: PHC budget for health promotion x 100 
 
Denominator: PHC budget 
 
Period of measurement: Annually 
Source: Administrative information systems, national budget plan 
 
Explanation: Determining PHC investment for the promotion of health 
 
 
Process: 
 
33. Proper implementation8 of policies for the promotion of human resources in 
PHC 
Numerator: Reports or evaluations of the financial needs arising from the 
implementation of the policy. 
 
Breakdown: No. of policy documents relating to the promotion of human resource in 
PHC, no. of workplaces that have specialists and committees charged with the 
promotion of human resources in PHC, no. of reports or evaluations on the financial 
needs arising from the implementation of the policy, number of reports submitted 
and considered by the senior management on the effects of monitoring and 
evaluation of the policy for the promotion of human resources in PHC. 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national programmes, national health 
accounts 
 
Explanation: Determining the effectiveness of policies for the promotion of human 
resources in PHC in terms of implementation. 
 
34. Proper implementation9 of policies for the proper distribution of human 
resources in PHC 
Numerator: No. of policies for the proper distribution of human resources in PHC 
that have been implemented by means of specific programmes 
 
Denominator: No. of overall policies for the proper distribution of human resources 
in PHC 
                                                        
8 To be defined by UNASUR 
9 To be defined by UNASUR 
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Period of measurement: Annually 
 
Source: Administrative information systems, national programmes, national health 
accounts 
 
Explanation: Determining the distribution of human resources in PHC in terms of 
policy implementation. Health workers are often concentrated in urban areas, while 
rural and remote environments lack basic healthcare. 
 
35. Number of PHC training institutions 
Numerator: No. of PHC training institutions 
 
Denominator: Total no. of institutions 
 
Period of measurement: Annually 
 
Source: Administrative information systems, health department licenses 
 
Explanation: Determining the labour force in terms of number of PHC training 
institutions 
 
36. Number of continuing training PHC programmes 
Numerator: No. of PHC training programmes   
 
Denominator: Total no. of programmes 
 
Period of measurement: Every two years 
 
Source: Administrative information systems, information systems in healthcare 
training centres 
 
37. Number of health promotion programmes 
Numerator: No. of health promotion programmes 
 
Denominator: Total no. of healthcare programmes 
 
Period of measurement: Annually 
 
Source: National and local administrative information systems, information systems 
at healthcare centres 
 
Explanation: Investment in health promotion and awareness-raising 
 
Output: 
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38. Density of PHC health workers  
Numerator: Total no. in the active PHC workforce x 100 
 
Denominator: Population of 1,000 inhabitants 
 
Period of measurement: Annually 
 
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of PHC human resources 
 
39. Density of PHC staff in rural areas (per 1000 inhabitants) 
Numerator: Total number of PHC staff in rural areas (active labour force) x 100 
 
Denominator: Population of 1000 
 
Period of measurement: 1-2 years 
 
Source: Administrative reporting system, population census, health establishments’ 
evaluations 
 
Explanation: Determining the availability of PHC staff in rural areas. 
 
40. Density of primary healthcare units  
Numerator: No. of primary care units 
 
Denominator: 10,000 inhabitants 
 
Period of measurement: Annually 
 
Source: Administrative information systems, population census, evaluations of health 
facilities 
 
Explanation: Determining access to family healthcare units 
 
41. Number of primary care units 
Numerator: No. of primary care units 
 
Denominator: N/A 
 
Period of measurement: Annually 
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Source: Administrative information systems, population census, evaluations of 
health facilities 
 
Explanation: Determining the availability and existence of USF 
 
42. Number of PHC graduates 
Numerator: No. of PHC graduates 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Records from training centres and universities 
 
Explanation: Determining the PHC labour force/Determining the social determinants 
 
43.  Distribution of PHC workers 
Numerator: No. of PHC workers by region/province x 100 
 
Denominator: Population of 10,000 people 
 
Period of measurement: Annually 
 
Source: Population census, administrative information systems 
 
Explanation: Determining the availability of and access to PHC staff 
 
44. Number of professionals that have completed continuous training 
programmes in PHC 
Numerator: No. of professionals who have completed PHC training programmes 
 
Denominator: No. of PHC professionals 
 
Period of measurement: Annually 
 
Source: Training centres, administrative information systems, continuing education 
programmes, no. of graduates 
 
Explanation: Determining the labour force in terms of quality of continuous training   
 
45. Percentage of children under age 5 who receive accompaniment (healthy 
children control, growth control) 
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Numerator: No. of children under 5 years receiving accompaniment (healthy children 
control, growth control) x 100 
 
Denominator: Total children under 5 years’ old 
 
Period of measurement: 1-5 years 
 
Source: Administrative reporting system, evaluations of health facilities 
 
Explanation: Determining the accompaniment of healthy children 
 
46. Coverage of adult patients with diabetes/hypertension 
Numerator: Number of people with diabetes/hypertension receiving public services 
 
Denominator: Total number of people with diabetes/hypertension with a need for 
services 
 
Period of measurement: Every 2 years 
 
Source: Centre reporting system, household survey 
 
Explanation: Percentage of people with diabetes/hypertension who use public 
services 
 
47. Number of brochures, advertisements or other distributed media to promote 
healthy lifestyles 
Numerator: No. of pamphlets distributed 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Reporting centres, local and national administrative information systems, 
health centre information systems 
 
Explanation: Determining the effort in the promotion of healthy lifestyles 
 
48. Coverage for the promotion of the health of people of all ages 
Numerator: No. of consultations after a health promotion campaign 
 
Denominator: No. of consultations a year before a health promotion campaign 
 
Period of measurement: Annually 
 
Source: Administrative information systems at health centres 
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Explanation: Measuring the effectiveness of actions of public promotion for all ages, 
assessing health promotion 
 
49. SDG 3, Sub-meta 8: Percentage of births attended by skilled health workers 
Numerator: No. of births attended by qualified health workers (doctors, nurses or 
midwives) trained in obstetrical care 
 
Denominator: The total number of live births in the same period 
 
Period of measurement: Every 2 years 
 
Source: Survey of households, centre reporting systems 
 
Explanation: Percentage of births attended by health workers during a specified 
period of time 
 
Outcome: 
 
50. Percentage of homes whose members have to travel more than 1 hour to get 
to the nearest primary healthcare centre 
Numerator: No. of households traveling for more than 1 hour to get to the nearest 
PHC healthcare centre x 100 
 
Denominator: Total number of households 
 
Period of measurement: Annually 
 
Source: Sanitary facilities database, geospatial modelling and analysis 
 
Explanation: Determining physical access to health 
 
51. Percentage of first level PHC consultations 
Numerator: No. of first level PHC consultations x 100 
 
Denominator: Total no. of consultations 
 
Period of measurement: Annually 
 
Source: Health centre reporting systems, administrative information system, 
evaluations of health centres, population-based health surveys 
 
Explanation: Determining demand for PHC consultations 
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52. Immunisation coverage for each vaccine in the national schedule 
Numerator: The number of individuals in the target group for each vaccine given the 
last dose recommended in the series. For vaccines in the infant immunisation 
schedule, this would be the number of children aged 12-23 months who have 
received vaccines specified for before their first birthday. 
 
Denominator: The total number of individuals in the target group for each vaccine. 
For vaccines in the infant immunization schedule, this would be the total number of 
infants. 
 
Period of measurement: Annually 
 
Source: Centre reporting system, household survey 
 
Explanation: Percentage of the desired population that has received the final 
recommended dose for each vaccine recommended in the national schedule of 
vaccines. This should include all vaccines within a country’s routine immunisation 
schedule. 
 
53. Percentage of diabetics in the Hbc<6 control programme 
Numerator: No. of diabetics in the Hbc<6 control programme x 100 
Denominator: Total no. of diabetics  
 
Period of measurement: Annually 
 
Source: Population-based health surveys, health centre information systems, 
evaluation of health centres 
 
Explanation: Determining the proportion of diabetics with low Hcb that are in a 
control program 
 
54. Percentage of patients with hypertension in the diastolic <90 control 
programme 
Numerator: No. of patients with hypertension in the diastolic <90 control 
programme x 100 
 
Denominator: Total no. of patients with hypertension  
 
Period of measurement: Annually 
 
Source: Population-based health surveys, health centre information systems, 
evaluation of health centres 
 
Explanation: Determining the percentage of assistance for people suffering from 
hypertension 
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55. SDG 3, Sub-meta 8 
a. Coverage of antenatal care (+ 4 visits) 
 
Numerator: Total no. of women who attended a NPC at least once x 100 
 
Denominator: Total no. of births 
 
Period of measurement: Every five years 
 
Source: National survey of demography and health-ENDS, civil records 
 
Explanation: Determining the proportion of pregnant women seen at least four times 
during pregnancy by skilled health workers for reasons related to the pregnancy. 
 
b. Immunisation coverage (full or DTP3) 
 
Numerator: No. of persons covered by the immunization 
 
Denominator: Total population 
 
Period of measurement: Annually 
 
Source: National administrative information systems, health centre information 
systems, population census, 
 
Explanation: Determining the immunization coverage to make it affordable 
 
Impact: 
 
56. Percentage of households with affordable primary healthcare coverage 
Numerator: No. of households with PHC coverage x 100 
 
Denominator: Total no. of households. 
 
Period of measurement: Annually 
 
Source: Population census, administrative information system, health centre 
information systems 
 
Explanation: Determining the affordability and coverage of PHC 
 
57. Prevalence of anaemia in children aged 6-59 months 
Numerator: Number of children aged 6-59 months with a level of haemoglobin 
below 110 g/L, adjusted for altitude. 
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Denominator: Total number of children aged 6-59 months who had levels of 
haemoglobin obtained during the survey. 
 
Period of measurement: Every 3-5 years 
 
Source: Population-based health surveys 
 
Explanation: Determining the nutritional status of the population 
 
58. Percentage of children under 5 who are malnourished (moderate and severe) 
Numerator: Number of children aged 0-59 months with malnutrition, x 100 
 
Denominator: Total number of children aged 0-59 months. 
 
Period of measurement: Every 3-5 years 
 
Source: National nutrition surveys 
 
Explanation: Measurement of nutrition and risk 
 
 
Primary health care: regional level 
 
Input: 
 
59. Expenditure of UNASUR in responding to the PHC strategy for training 
Numerator: UNASUR expenditure on training for the PHC strategy 
 
Denominator: Total expenditure of UNASUR 
 
Period of measurement: Annually 
 
Source: Budgets and reports from UNASUR and ISAGS 
 
Explanation: Determining the regional effort for PHC training and response to the 
PHC strategy 
 
60. Expenditure in respect of PHC coordination and meetings 
Numerator: UNASUR expenditure on meetings and coordination for the PHS strategy 
 
Denominator: Total expenditure of UNASUR 
 
Period of measurement: Annually 
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Source: Budgets and reports from UNASUR and ISAGS 
 
Explanation: Determining the regional effort to achieve the objectives of the PHC 
strategy 
 
61. Number of resolutions/regional agreements to respond to PHC access 
Numerator: No. of resolutions/regional agreements in relation to access to PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information systems of UNASUR and ISAGS 
 
Explanation: Determining the regional political effort in the response of the PHC 
strategy 
 
62. Total expenditure of UNASUR in PHC 
Numerator: Total expenditure of UNASUR in PHC x 100 
 
Denominator: Total health expenditure of UNASUR  
 
Period of measurement: Annually 
 
Source: Administrative information systems of UNASUR and ISAGS 
 
Explanation: Determining regional investment in PHC. Promoting critical reflection 
and raising awareness of the importance of the economic dimension as a crucial 
component in decision-making related to the adoption of new health technologies. 
 
Process: 
 
63. Number of training sessions to train PHC experts 
Numerator: No. of training sessions to train PHC experts  
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS 
 
Explanation: Determining regional investment in strategic staff training. 
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64. Number of experts leading UNASUR proposals in multilateral spaces 
Numerator: No. of experts leading UNASUR proposals in multilateral spaces 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, multilateral space 
meetings information system (CELAC, WHO, OAS, etc.) 
 
Explanation: Determining the representation of UNASUR proposals in multilateral 
spaces 
 
65. Number of regional meetings/events to discuss actions to improve the PHC 
strategy 
Numerator: No. of meetings and regional events funded/organised by UNASUR in 
relation to the PHC strategy 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, national 
administrative information systems 
 
Explanation: Determining the effort of coordinating the regional response to 
improving the PHC strategy. Dissemination of knowledge on good practices of the 
countries, reinforcing block health policies and increasing the number of bilateral 
cooperations between the countries. Establishing the commitment of member states 
to strengthen policies on access to medicines. 
 
66. Number of countries participating in coordination meetings on access to PHC 
Numerator: No. of countries participating in coordination meetings on access to PHS 
 
Denominator: Total no. of UNASUR member countries 
 
Period of measurement: Annually 
 
Source: Administrative information system and reports of UNASUR and ISAGS 
 
Explanation: Determining the level of commitment from the countries for regional 
PHC coordination. 
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67. Proper implementation10 of PHC policies from UNASUR agreements 
Numerator: No. of countries that have implemented policies adequately from 
UNASUR agreements on PHC (documents and programmes, budgets for certain PHC, 
based on UNASUR agreements. 
 
Denominator: Total number of UNASUR member countries 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, NGO information 
system. Ministry of health information system and national administrative 
information system 
 
Explanation: Determining the influence of the agreements made at UNASUR for PHC 
policies 
 
68. Number of regional working groups to discuss actions to improve access to 
PHC 
Numerator: No. of regional working groups funded/organised by UNASUR that 
discussed actions to improve access to PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, national 
administrative information systems 
 
Explanation: Determining the effort of coordinating the regional response to 
improving the PHC strategy. Dissemination of knowledge on good practices of the 
countries, reinforcing block health policies and increasing the number of bilateral 
cooperations between the countries. Establishing the commitment of Member 
Countries to strengthen policies on access to medicines. 
 
69. Number of acts, agreements from coordination meetings on access to PHC 
Numerator: No. of acts and agreements from coordination meetings 
funded/organised by UNASUR on access to PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: UNASUR and ISAGS reports and administrative information system 
                                                        
10 To be defined by UNASUR 
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Explanation: Determining the intensity of agreement production for PHC at regional 
level 
 
70. Number of meetings with other regional bodies on the issue of access to PHC 
Numerator: No. of meetings with other regional bodies, such as OAS, Mercosur, and 
CAN, on access to PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR, ISAGS, Mercosur, Alba, 
Andean Community, OEA, CELAC; National administrative information systems 
 
Explanation: Determining the regional inter-organisational effort. 
 
71. Number of projects with other regional bodies on the issue of access to PHC 
Numerator: No. of projects with other agencies, such as OAS, Mercosur, CAN, PAHO, 
CRIES, on the issue of PHC 
 
Denominator: Total number of projects on access to PHC 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, information 
system of other organisations at global, regional, national and local level. 
 
Explanation: Determining the level of coordination and integration between 
organisations at different levels on PHC 
 
Output: 
 
72. Number of proposals made to respond to the access to PHC at global level 
Numerator: No. of proposals made to respond to the access to PHC at global level 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, WHO 
administrative information system 
 
Explanation: Determining the effort of UNASUR in formulating proposals at global 
level 
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73. Number of trained experts that replicate the learning  
Numerator: No. of experts trained and funded/organised by UNASUR that replicate 
PHC learning 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS and the PHC 
courses from these organisations. 
 
Explanation: Determining the renewal of PHC experts 
 
74. Number of experts trained in the implementation of PHC 
Numerator: No. of experts trained and funded/organised by UNASUR for the 
implementation of PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS 
 
Explanation: Determining the workforce trained in PHC 
 
75. Number of countries with the highest rate of distribution of PHC services 
Numerator: No. of countries with the highest rate of distribution of PHC services   
 
Denominator: Total no. of UNASUR member countries 
 
Period of measurement: Annually 
 
Source: Administrative information system of ISAGS, evaluations in the health 
sectors at national level 
 
Explanation: Determining the countries with the highest rate of distribution of PHC 
services for detecting good practices 
 
76. Number of countries with improved PHC strategies 
Numerator: No. of countries with improved PHC strategies 
 
Denominator: N/A 
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Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS 
 
Explanation: Determining the influence of the work of UNASUR/ISAGS in national 
programmes enhanced for PHC. 
 
77. Number of partnerships with other agencies on issues of access to PHC 
Numerator: No. of partnerships with other agencies on issues of access to PHC 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system and reports from UNASUR and ISAGS, 
WHO information system, at national level, NGOs in PHC, etc. 
 
Explanation: Determining the coordination effort among the agencies working in 
PHC 
 
Outcome: 
 
78. Number of common positions on PHC from UNASUR in multilateral spaces 
Numerator: No. of common positions on PHC from UNASUR in multilateral spaces 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Information systems of UNASUR, ISAGS and multilateral spaces (WHO, 
PAHO, etc.) 
 
Explanation: Determining the influence of the UNASUR proposal on the issue of PHS 
at multilateral level 
 
79. Average rate of access to PHC among member states 
Numerator: Total of national estimates of access to PHC 
 
Denominator: No. of UNASUR member states (12) 
 
Period of measurement: 1-5 years  
 
Source: Information systems of ISAGS, national administrations, population-based 
surveys  
 
 78 
Explanation: Determining the regional average for access to PHC 
 
Access to medicines: national level 
 
Input: 
80. Public investment in pharmaceutical education 
Numerator: Amount of public investment - spending power and capital of the 
budgets of the Government, foreign loans and grants (including contributions from 
international agencies and non-governmental organisations) – in pharmaceutical 
education in public institutions 
 
Denominator: Amount of public investment in education  
 
Period of measurement: Annually 
 
Source: National information systems, accounts pharmaceutical training centres and 
universities 
 
Explanation: Determining the public effort in pharmaceutical education 
 
81. Existence of human resources policies for pharmaceutical resources 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Administrative and legislative information system 
 
Explanation: Determining the political effort in terms of human resources in 
pharmaceutical resources 
 
82. Existence of appropriate distribution policies of human resources in 
pharmaceutical resources 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Administrative and legislative information system 
 
Explanation: Determining the political effort for proper distribution of human 
resources on access to medicines 
 
83. Existence of promotion rules for the use of generics  
Answer: YES/NO 
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Period of measurement: Annually 
 
Source: Administrative and legislative information system 
 
Explanation: Determining the political effort in promoting use of generics 
 
84. Existence of national production promotion rules 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Administrative and legislative information system 
 
Explanation: Determining the political effort in the promotion of national production 
 
85. Existence of a list of medications that are guaranteed by the Government:  
Answer: YES/NO 
 
Period of measurement: Annual 
  
Source: Administrative information system 
 
Explanation: Determining the extent of drug coverage 
 
 
86. Is financing in the public system complete?  
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Budgets and administrative information system 
 
Explanation: Determining the level of funding of the public system of medicines  
 
87. Is financing in the private system complete? 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: Budgets and administrative information system 
 
Explanation: Determining the level of funding of the public system of medicines  
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88. Current expenditure for imports of medicines in relation to total imports 
Numerator: Current expenditure for imports of medicines 
 
Denominator: Current expenditure in total imports 
 
Period of measurement: Annually 
 
Source: National accounts 
 
Explanation: Determining dependence on pharmaceutical trade and spending on 
medicines imported in relation to other imports to see if the purchase cost is high. 
 
89.   Are the regional regulations (UNASUR/MERCOSUR) regarding joint 
purchases applied in the country? 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: National accounts, ISAGS information system 
 
Explanation: Determining the scope of the regional law on joint purchases 
 
Process: 
 
90. Number of public and private pharmaceutical education institutions 
Numerator: No. of public and private pharmaceutical education institutions 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative information system 
 
Explanation: Determining the possibilities of pharmaceutical education 
 
91. Proper implementation11 of the policies for the promotion of total 
pharmaceutical human resources 
Numerator: No. of policies adequately implemented for the promotion of total 
pharmaceutical human resources through specific programmes 
Denominator: Total no. of policies implemented for the promotion of human 
resources 
                                                        
11 To be defined by UNASUR 
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Breakdown: Number and type of policy documents relating to promotion of 
pharmaceutical human resources, number of workplaces that have specialists and 
committees charged with the promotion of total pharmaceutical human resources, 
number of reports or evaluations on financial needs arising from the implementation 
of the policy, number of reports submitted and considered by the senior 
management for the purpose of the monitoring and evaluation of the policy to 
promote pharmaceutical human resources. 
Period of measurement: Annually 
Source: Administrative information systems, national programmes, national health 
accounts 
Explanation: Determining the effectiveness of policies for the promotion of 
pharmaceutical human resources in terms of proper implementation. 
 
92. Proper implementation12 of policies for the proper distribution of total 
pharmaceutical human resources 
Numerator: No. of policies adequately implemented for the distribution of total 
pharmaceutical human resources through specific programmes 
Denominator: Total no. of policies proposed for the distribution of human resources 
Period of measurement: Annually 
Source: Administrative information systems, national programmes, national health 
accounts 
Explanation: Determining the distribution of pharmaceutical human resources in 
terms of policy implementation. Health workers are often concentrated in urban 
areas, while rural and remote environments lack basic healthcare. 
93. Proper implementation13 of promotion rules for the use of generics 
Numerator: No. of documents, evaluations, meetings, etc. 
Denominator: N/A 
Period of measurement: Annually 
Source: Administrative information systems, national programmes, national health 
accounts 
Explanation: Determining the implementation of promotion rules for the use of 
generic standards. 
94. Existence of a public-private alliance to development different products 
Answer: YES/NO 
Period of measurement: Annually 
Source: Administrative information systems, national programmes, programmes of 
                                                        
12 To be defined by UNASUR 
13 To be defined by UNASUR 
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private institutions 
Explanation: Determining the cooperation between the public sector and the private 
sector, exchange of good practices, exchange of projects and financing. 
 
95. Existence of periodic updating: is the list of specialised medications updated 
periodically? 
Numerator: No. of times a year the drug list is updated 
Denominator: N/A 
Period of measurement: Annually 
Source: Administrative information systems, Ministry of health 
Explanation: Determining the updating of the list of drugs in relation to   
96. Proper implementation14 of policies from agreements made by UNASUR on 
access to medicines 
Numerator: No. of countries that have implemented policies adequately from 
UNASUR agreements on access to medicines (documents and programmes, budgets 
for access to medicines, based on agreements with UNASUR) 
 
Denominator: Total no. of member countries 
 
Period of measurement: Annually 
 
Source: Administrative information systems, national programmes, national health 
accounts 
 
Explanation: Determining the impact and scope of UNASUR at national level in 
relation to the implementation of agreements made by UNASUR. 
 
Output: 
97. Distribution of graduate pharmaceutical workers in the country (urban and 
rural areas 
Numerator1: Total no. of graduate pharmaceutical workers working in urban areas 
 
Numerator2: Total no. of graduate pharmaceutical workers working in rural areas 
 
Denominator: Total no. of graduate pharmaceutical personnel  
Period of measurement: Annually 
Source: Records from universities, training centres, information systems and 
evaluations of health centres 
Explanation: Determining the resumption of the pharmaceutical workforce 
                                                        
14 To be defined by UNASUR 
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98. Density of pharmacists  
Numerator: Total number of active pharmaceutical workers x 100 
Denominator: Population of 1000 inhabitants 
Period of measurement: Annually 
Source: Administrative reporting system, population census, health establishments’ 
evaluations 
Explanation: Determining the availability of pharmacists. 
 
99. Total number of pharmacists in the country 
Numerator: Total number of pharmacists 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Administrative reporting system, population census, evaluations of health 
facilities 
 
Explanation: Determining the actual level of pharmaceutical human resources 
 
100. Density of pharmaceutical workers in rural areas x 1000 inhabitants 
Numerator: Total number of pharmacists in rural areas (active labour force) x 100 
Denominator: Population of 1000 
Period of measurement: Annually 
Source: Administrative reporting system, population census, health establishments’ 
evaluations 
Explanation: Determining the availability of pharmaceutical workers in rural areas. 
101. Percentage of national medication production 
Numerator: No. of medications produced in the national territory x 100 
 
Denominator: No. of medications imported and produced in the national territory 
 
Period of measurement: Annually 
 
Source: National accounts and data from pharmaceutical industries 
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Explanation: Determining the national production of medications to assess 
dependence of the market, prices of medicines, weight of the national 
pharmaceutical industry 
 
102. Existence of good practices for the manufacture of medicines 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: National legal system, national system regulating the national 
pharmaceutical industry 
 
Explanation: Determining the existence of good practices in the manufacture of 
medications 
 
103. Existence of pharmacovigilance practices 
Answer: YES/NO 
 
Period of measurement: Annually 
 
Source: National legal system, national system regulating the national 
pharmaceutical industry 
 
Explanation: Determining the existence of pharmacovigilance practices 
 
104. Percentage of medications produced in the country 
Numerator: No. of medications produced in the country x 100 
Denominator: No. of imported medications 
Period of measurement: Annually 
Source: Administrative reporting system 
Explanation: Determining the strength of the medications market at national level 
and the level of independence. 
 
105. How many joint purchases of medications took place with other 
countries? 
Numerator: Import value derived from joint purchases of medications with other 
countries 
Denominator: Total value of imported medications 
 
Period of measurement: Annually 
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Source: National accounts, regional and local administrative information systems, 
health centre administration systems 
 
Explanation: Determining the proportion of cooperation for the import of 
medications 
 
Outcome: 
 
106. Annual variation of the (retail) market price index 
Numerator: Market price index for the year preceding the year studied – market 
price index for the year studied x 100 
 
Denominator: Price index for the previous year 
 
Period of measurement: Annually 
 
Source: Economic information systems, administration information systems 
 
Explanation: Determining the rate of inflation 
 
107. Amount of medicines out of stock in health establishments 
Numerator: No. of health facilities that had a shortage of at least one medication 
from the national list of essential drugs in the past 12 months 
 
Denominator: Total no. of medications on the essential drug list 
 
Period of measurement: Annually 
 
Source: Inventories from health centres, standard information systems 
 
Explanation: Determining if medications and essential products are available in 
health facilities 
108. Free coverage of HIV/AIDS medicines 
Numerator: No. of countries with free coverage of HIV/AIDS medicines. 
 
Denominator: Total no. of countries  
 
Period of measurement: 1-5 years  
 
Source: National administrative information system, Ministry of health 
 
Explanation: Determining public policies in terms of coverage of HIV/AIDS 
medications  
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109. Free basic and essential medication coverage 
Numerator: No. of countries with free basic and essential medication coverage 
according to the national essential medications list  
 
Denominator: Total no. of countries  
 
Period of measurement: 1-5 years  
 
Source: National administrative information system, Ministry of health 
 
Explanation: Determining public policies in the field of basic and essential medication 
coverage  
 
110. Relationship between domestic and international prices 
Numerator: Average price of specific national medications for a health area 
 
Denominator: Average price of specific international medications for a health area 
 
Period of measurement: Annually 
 
Source: Administrative reporting system, prices database, national and international 
pharmaceutical companies 
 
Explanation: Determining the difference between domestic and international prices 
to see if domestic prices are comparable to the international average. 
 
111. Percentage of import of medications 
Numerator: Import of medications x 100 
 
Denominator: Drug consumption 
 
Period of measurement: Annually 
 
Source: National accounts 
 
Explanation: Determining the national demand for medications produced in other 
countries. 
112. Percentage of export of medications 
Numerator: Export value of medications x 100 
Denominator: Total value of exports 
Period of measurement: Annually 
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Source: National accounts 
Explanation: The value of the medications exported, including goods, 
transport, freight, insurance, royalties, license fees and other services. 
113. SDG 3, sub-meta 8: universal health coverage including protection 
against financial risks, access to essential services and quality of health and 
access to safe, effective and affordable medications and vaccines for all 
a. Percentage of people with health coverage including medications and 
vaccines   
 
Numerator: No. of people with health coverage, including medications and vaccines 
x 100 
 
Denominator: Total population 
 
Period of measurement: 1-5 years 
 
Source: Data from health facilities, population-based surveys 
 
Explanation: Determining the progress towards 100% universal health coverage 
 
b. Existence of subsidies for medications for low-income people 
 
Numerator: No. of countries that have policies of subsidies for medications for low-
income people  
 
Denominator: Total no. of countries  
 
Period of measurement: 1-5 years 
 
Source: Health establishment data, Ministry of health 
 
Explanation: Determining the progress towards 100% universal health coverage 
 
114. SDG 3b: Research and production of vaccines and medicines and the 
supply of basic vaccines, in accordance with the Doha Declaration which 
establishes the right of the developing countries to make maximum use of the 
provisions of the TRIPS Agreement, the relationship to flexibility to protect 
public health and in general provide access to medications for all 
a. Amount of compulsory licences granted 
 
Numerator: No. of compulsory licences granted 
Denominator: N/A 
Period of measurement: Annually 
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Source: National legislative and administrative system 
 
Explanation: Determining the scope of TRIPS flexibilities  
 
b. Amount of national pharmaceutical patents 
 
Numerator: No. of national pharmaceutical patents 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: National patent administrative system 
 
Explanation: Determining the level of national pharmaceutical patents 
 
c. Percentage of participation of the domestic industry in domestic sales of 
medications 
 
Numerator: No. of national industries participating in domestic sales of medications 
x 100 
 
Denominator: Total no. of industries participating in domestic sales of medications 
 
Period of measurement: 1-2 years  
 
Source: Domestic sales of medications information system 
Explanation: Determining the representation of national pharmaceutical industries in 
proportion to international representation 
 
115. SDG 3b: percentage of the population with access to basic medicines 
and out-of-pocket and sustainable supplies 
Numerator: Population breakdown (physical, social and financial) with access to 
affordable essential medications on a sustainable basis 
 
Denominator: Total population breakdown by country/territory 
 
Period of measurement: 1-5 years 
 
Source: National health surveys 
 
Explanation: Determining accessibility to essential medications 
 
116. SDG 3, Sub-meta 8 
a. Tuberculosis treatment/coverage ratios                        
b. HIV/AIDS treatment/coverage ratios 
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c. Diabetes treatment/coverage ratios 
d. Hypertension treatment/coverage ratios 
 
Numerator1: No. of persons receiving treatment for Tuberculosis, HIV/AIDS, 
diabetes, hypertension  
 
Numerator 2: No. of persons receiving care for Tuberculosis, HIV/AIDS, diabetes, 
hypertension  
 
Denominator: No. of people affected by Tuberculosis, HIV/AIDS, diabetes, 
hypertension 
 
Period of measurement: Annually 
 
Source: Health centre information systems, administrative information systems, 
Health centre surveys 
 
Explanation: Determining access to treatments and coverage for Tuberculosis, 
HIV/AIDS, diabetes, hypertension 
 
117. SDG 3, sub-meta 8: percentage of minors with a full vaccination 
scheme   
Numerator: No. of minors with a full vaccination scheme x 100 
 
Denominator: Total no. of minors in the country/territory 
 
Period of measurement: 1-5 years 
 
Source: Population-based health surveys, routine information systems 
 
Explanation: Determining the percentage of minors who have a full vaccination 
scheme 
 
Access to medicines: regional level 
 
Input: 
 
118. Total UNASUR expenditure allocated for access to medicines 
Numerator: Total UNASUR expenditure to respond to access to medications in 
terms of: meetings, workshops, documents and logistics, among others, x 100 
Denominator: Total health expenditure of UNASUR 
Period of measurement: Annually 
Source: Budget for formation system of UNASUR and ISAGS 
Explanation: Determining the effort of UNASUR concerning access to 
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medications 
 
119. Expenditure of UNASUR for training  
Numerator: Total expenditure of UNASUR for training experts x 100 
Denominator: Total health expenditure of UNASUR 
Period of measurement: Annually 
Source: Budget for formation system of UNASUR and ISAGS 
Explanation: Determining the financing and training effort to improve access to 
medications 
 
120. UNASUR expenditure in respect of meetings and coordination on 
access to medications 
Numerator: UNASUR expenditure in respect of meetings and coordination on 
access to medications 
Denominator: Total health expenditure of UNASUR  
Period of measurement: Annually 
Source: Budget for formation system of UNASUR and ISAGS 
Explanation: Determining financing efforts at the level of UNASUR to improve 
access to medications 
 
121. Number of regional resolutions/agreements to respond to access to 
medications 
Numerator: No. of regional resolutions/agreements funded/organised by 
UNASUR concerning access to medications 
Denominator: N/A 
Period of measurement: Annually 
Source: Information reporting system of UNASUR and ISAGS, press releases 
Explanation: Determining the political activity of UNASUR concerning access to 
medications, determining the activity of other regional bodies on the issue of 
access to medications 
 
122. Database of prices of medications: total cost of the project for the 
creation of a South American price database 
Numerator: Total cost of the project for the creation of a South American price 
databases [meetings, logistics, personnel, training] 
Denominator: Total health expenditure of UNASUR  
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Period of measurement: Annually 
Source: Budget for formation system of UNASUR and ISAGS 
Explanation: Determining financing efforts for the price database project 
 
123. Joint purchase of medicines: subscription/signing of agreement for 
acquisition of medicines through the strategic PAHO/WHO fund 
Numerator: No. of national subscriptions for the acquisition of medications 
purchased jointly (through the strategic PAHO/WHO fund) 
Denominator: Total no. of member countries 
Period of measurement: Annually 
Source: Information system of the strategic PAHO, WHO fund, ISAGS, UNASUR 
Explanation: Determining the evolution of subscriptions to the strategic fund 
for joint purchases of medications at regional level 
 
 
Process: 
 
124. Number of experts leading UNASUR proposals in multilateral spaces 
Numerator: No. of experts on access to medications leading proposals from 
UNASUR in multilateral spaces 
Denominator: Total no. of experts on access to medications 
Period of measurement: Annually 
Source: ISAGS/UNASUR information system and planning of multilateral space 
events (OPS, WHO, etc.) 
Explanation: Determining the effort and reach of UNASUR in multilateral spaces 
 
125. Number of regional meetings/events to discuss actions to improve 
access to medications. 
Numerator: No. of meetings/regional events funded/organised by UNASUR to 
discuss actions to improve access to medications 
Denominator: N/A 
Period of measurement: Annually 
Source: Reporting systems of UNASUR, ISAGS, Mercosur, Andean Community, 
OAS and other regional bodies 
Explanation: Determining the level of coordination efforts at regional level to 
improve access to medications 
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126. Number of countries that have participated in coordination meetings 
on access to medications 
Numerator: No. of countries that have participated in coordination meetings 
funded/organised by UNASUR on access to medications 
 
Denominator: Total no. of countries 
 
Period of measurement: Annually 
 
Source: Information reporting system of UNASUR and ISAGS 
 
Explanation: Determining the level of engagement of member countries in improving 
access to drugs at the level of UNASUR 
 
127. Appropriate regional implementation15 of policies based on 
agreements made by UNASUR on access to medications 
Numerator: No. of countries that have implemented policies based on UNASUR 
agreements on access to medications (documents and programmes, budgets for 
access to medications, based on agreements with UNASUR) 
 
Denominator: Total no. of UNASUR countries 
 
Period of measurement: Annually 
 
Source: Administrative information system of UNASUR and ISAGS, NGO information 
system 
 
Explanation: Determining the influence and scope of the agreements made by 
UNASUR on policies for access to medications 
 
128. Number of regional working groups to discuss actions to improve 
access to medications 
Numerator: No. of regional working groups funded/organised by UNASUR on 
the issue of access to medications 
Denominator: N/A 
Period of measurement: Annually 
Source: Information reporting system of UNASUR and ISAGS 
Explanation: Determining the regional consultation of working groups to 
improve access to medications 
 
                                                        
15 To be defined by UNASUR 
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129. Number of acts, agreements from coordination meetings on access to 
medications 
Numerator: No. of acts and agreements from coordination meetings financed and 
organised by UNASUR   
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Information reporting system of UNASUR and ISAGS 
 
Explanation: Determining the region’s political effort on the issue of access to 
medications 
 
130. Number of meetings of other regional bodies on access to medications 
in which UNASUR or other member countries participated. 
Numerator: No. of meetings of other bodies on the issue of access to 
medications in which UNASUR or other member countries participated. 
Denominator: N/A 
Period of measurement: Annually 
Source: Information reporting system of UNASUR and ISAGS, information 
system of the ministries of health, information system of participants in events 
held by regional bodies, information system of participants in events held my 
multilateral bodies 
Explanation: Determining the involvement of UNASUR and its member 
countries in meetings organised by third parties 
 
131. Number of partnerships with other regional agencies on issues of 
access to medications 
Numerator: No. of partnerships with other regional bodies on the issue of access to 
medications 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Information system of UNASUR, ISAGS and other agencies: PAHO, WHO, 
NGOs  
 
Explanation: Determining the cooperative effort of various agencies to improve 
access to medications 
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132. Medication price database: Number of meetings between the 
countries for the review and implementation of the project 
Numerator: No. of meetings among member countries for the review and 
implementation of the medication price database project 
Denominator: N/A 
Period of measurement: Annually 
Source: Information event system of UNASUR and ISAGS 
Explanation: Determining the improvement effort and the implementation of 
the medication price database project 
133. Price database: Number of countries using the list from the medication 
price database 
Numerator: No. of countries which use the price database list 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: ISAGS/UNASUR information system 
 
Explanation: Determining participation specifically in using the price database 
 
134. Price database: proper implementation16 of the medication price 
database 
Numerator: Implementation budgets, action programmes and reports for the 
medication price database 
 
Denominator: Budget planned for the price database 
 
Period of measurement: Annually 
 
Source: UNASUR and ISAGS information system 
 
Explanation: Determining the effectiveness in the implementation of the price 
database 
 
135. Price database: number of countries that reported at least 40% of the 
listed medications 
Numerator: No. of countries that reported at least 40% of the medications 
listed in the price database 
Denominator: N/A 
                                                        
16 To be defined by UNASUR 
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Period of measurement: Annually 
Source: Information reporting systems of ISAGS, national ministries of health 
Explanation: Determining the extent of the use of the price database 
136. Joint purchase of medications: number of medications traded between 
the UNASUR member countries 
Numerator: No. of medications traded between UNASUR member countries on 
the issue of the joint purchase of medications 
Denominator: N/A 
Period of measurement: Annually 
Source: Information system of the strategic fund of the PAHO, WHO, ISAGS, 
UNASUR  
Explanation: Determining the specific implementation of the joint purchasing 
strategy in respect of negotiations of medications 
 
137. Joint purchase of medications: number of preparatory meetings 
Numerator: No. of preparatory meetings to implement the joint purchasing of 
medications 
Denominator: N/A 
Period of measurement: Annually 
Source: Information system of the strategic fund of the PAHO, WHO, ISAGS, 
UNASUR 
Explanation: Determining the training and cooperation efforts of regional 
agencies to implement joint purchasing 
 
138. Joint purchase of medications: Proper implementation17 in the joint 
purchase of medications in countries 
Numerator: No. of countries that buy medications jointly, within the strategic 
PAHO/WHO fund. 
Denominator: N/A  
Period of measurement: Annually 
Source: Information system of the strategic PAHO, WHO fund, ISAGS, UNASUR, 
national import accounts 
Explanation: Determining the implementation of the strategy for the joint 
purchase of medications 
 
                                                        
17 To be defined by UNASUR 
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139. Joint purchase of medications: number of subscribed countries 
Numerator: No. of subscribed countries 
Denominator: N/A 
Period of measurement: Annually 
Source: ISAGS/UNASUR information system 
Explanation: Determining the commitment of countries to the joint purchasing 
of medications strategy 
 
Output: 
 
140. Number of proposals to respond to global access to medications 
Numerator: No. of proposals made by UNASUR to respond to global access to 
medications 
 
Denominator: Total No. of proposals from UNASUR 
 
Period of measurement: Annually 
 
Source: Information event systems of UNASUR and ISAGS, press releases and 
reports, information reporting systems and planning by global organisations 
 
Explanation: Determining the scope of UNASUR in terms of global access to 
medications 
 
141. Number of experts trained in the field of access to medications 
Numerator: No. of experts trained and funded/organised by UNASUR on access to 
medications 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: ISAGS personnel information system 
 
Explanation: Determining the strategic workforce to improve access to medications 
 
142. Number of draft resolutions on medications approved by the Board of 
Health or Chancellors  
Numerator: No. of draft resolutions on medications approved by the Board of Health 
or Chancellors 
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Denominator: N/A 
 
Period of measurement: Annually 
 
Source: ISAGS/UNASUR information system 
 
Explanation: Determining the level of commitment of other stakeholders within the 
UNASUR at regional level 
 
143. Number of projects with other agencies on access to medications for 
the region 
Numerator: No. of projects with other organisations, such as Mercosur, CAN and 
OAS, on the issue of access to medications 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: Information system of ISAGS/UNASUR, NGOs, WHO, PAHO, regional bodies 
 
Explanation: Determining the coordination of various levels in respect of projects to 
improve access to medications in the region 
 
144. Joint purchase of medications: medications purchased through the 
strategic PAHO/WHO fund 
Numerator: Amount of medications purchased jointly 
Denominator: N/A 
Period of measurement: Annually 
Source: ISAGS/UNASUR information system 
Explanation: Determining the implementation of the joint purchasing of 
medications project 
 
145. Joint purchase of medications: total volume of medications purchased 
through the strategic PAHO/WHO fund 
Numerator: Total no. of medications purchased jointly 
Denominator: N/A 
Period of measurement: Annually 
Source: PAHO/WHO information systems, national accounts, national balance 
sheets 
Explanation: Determining the level of commitment to the joint purchase of 
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medications 
 
Outcome: 
 
146. Number of common positions of UNASUR on access to medications 
approved in multilateral spaces 
Numerator: No. of common positions of UNASUR on access to drugs approved in 
multilateral areas 
 
Denominator: N/A 
 
Period of measurement: Annually 
 
Source: UNASUR/ISAGS, multilateral space information systems (WHO, PAHO, UN, 
etc.) 
 
Explanation: Determining the scope of UNASUR at global and multilateral level 
 
147. Average rate of access to medications between member states 
Numerator: Total of national estimates of access to medications 
 
Denominator: Total no. of UNASUR member states (12) 
 
Period of measurement: 1-5 years  
 
Source: Information systems of ISAGS, national administrations, population-based 
surveys  
 
Explanation: Determining the regional average for access to medications 
 
148. Medication price database: percentage of products that experienced a 
reduction in price asymmetries between the UNASUR member states 
Numerator: No. of medications in the price database whose prices are below 
the average of the prices of the UNASUR member countries x 100 
Denominator: No. of medications on the database list 
Period of measurement: Annually 
Source: Information systems of ministries of health, NGOs, national accounts, 
medication price database 
Explanation: Determining if the price database has helped to reduce price 
asymmetries between countries 
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149. Joint purchase of medications: percentage of population with 
coverage from the medications purchased under this framework by disease 
Numerator: No. of people suffering from disease x who have coverage from the 
medication needed in the joint purchase framework 
 
Denominator: Population suffering from disease x 
 
Period of measurement: Annually 
 
Source: National administrative information, health centre and pharmacy 
information systems  
Explanation:  
 
150. Joint purchase of medications: regional decrease in purchase price of 
medications 
Numerator: The difference between the index of medication prices in year X 
and year Y 
Denominator: Price index in year X 
Period of measurement: Annually, biannually 
Source: Information systems of pharmaceutical companies 
Explanation: Determining the evolution of medication prices after having 
implemented the price database and the joint purchasing strategy 
 
151. Joint purchase of medications: reduction in the average price in 
comparison with the international average 
Numerator: The international average price in year Y less the difference 
between the medication price index in year X and year Y at regional level 
Denominator: Average price 
Period of measurement: 1-5 years 
Source: Information system of WHO, PAHO, ISAGS 
Explanation: Determining the range of the price of medicines in the UNASUR 
region compared with international level and its evolution 
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Annex 2. Health-related Sustainable Development Goals and subgoals   
 
SDGs     
Total: 17 goals, 169 
targets and 100 indicators 
( more to be developed in 
the negotiations) 
   
Goals  Targets Indicators In addition, the following Complementary 
National Indicators relate to health according 
to the document  
1 End poverty in all 
its forms 
everywhere 
By 2030, reduce 
at least by half 
the proportion of 
men, women and 
children of all 
ages living in 
poverty in all its 
dimensions 
according to 
national 
definitions 
a. Multidimensional Poverty Index  
  By 2030 ensure 
that all men and 
women, 
particularly the 
poor and the 
vulnerable, have 
a. Percentage of eligible population covered by national 
social protection programs 
 
 
 
 
 
 101 
equal rights to 
economic 
resources, as well 
as access to basic 
services, 
ownership, and 
control over land 
and other forms 
of property, 
inheritance, 
natural 
resources, 
appropriate new 
technology, and 
financial services 
including 
microfinance 
 
 
 
 
 
 
 
  
2. End hunger, 
achieve food 
security and 
improved 
nutrition and 
promote 
sustainable 
agriculture 
By 2030 end 
hunger and 
ensure access by 
all people, in 
particular the 
poor and people 
in people, in 
particular the 
poor and people 
in vulnerable 
situations 
including infants, 
to safe, nutritious 
a. Proportion of population below minimum level of 
dietary energy consumption (MDG Indicator) 
 
b. Percentage of women of reproductive age (15-49) 
with anemia 
 
c. Prevalence of stunting and wasting in children under 5 
years of 
age 
 
d. Percentage of infants under 6 months who are 
exclusively breast 
fed 
• Percentage of births attended by skilled 
health personnel (MDG Indicator) 
• Antenatal care coverage (at least one visit 
and at least four visits) (MDG Indicator) 
• Post-natal care coverage (one visit) (MDG 
Indicator) 
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and sufficient 
food all year 
round 
 
e. Percentage of women (15-49) who consume at least 5 
out of 10 
defined food groups 
 
f. Percentage of population with shortfalls of: iron, zinc, 
iodine, 
vitamin A, folate, vitamin B12 [and vitamin D] 
 
g. Proportion of infants 6-23 months of age who receive 
a 
minimum acceptable diet 
 
h. Percentage children born with low birth weight 
 
  By 2030 end all 
forms of 
malnutrition, 
including 
achieving by 2025 
the 
internationally 
agreed targets on 
stunting and 
wasting in 
children under 5 
years of age, and 
address the 
nutritional needs 
of adolescent 
a. Percentage of women of reproductive age (15-49) 
with anemia 
 
b. Prevalence of stunting and wasting in children under 5 
years of age 
 
c. Percentage of infants under 6 months who are 
exclusively breast fed 
 
d. Percentage of population with shortfalls of: iron, zinc, 
iodine, vitamin A, folate, vitamin B12 [and vitamin D] 
 
e. Proportion of infants 6-23 months of age who receive 
a 
minimum acceptable diet 
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girls, pregnant 
and lactating 
women, and 
older persons 
 
f. Percentage of total daily energy intake from protein in 
adults 
3. Ensure healthy 
lives and 
promote well-
being for all at all 
ages 
By 2030 reduce 
the global 
maternal 
mortality ratio to 
less than 70 per 
100,000 live 
births 
a. Maternal mortality ratio (MDG Indicator) and rate 
 
b. Percentage of births attended by skilled health 
personnel (MDG 
Indicator) 
 
c. Antenatal care coverage (at least one visit and at least 
four visits) (MDG Indicator) 
 
d. Post-natal care coverage (one visit) (MDG Indicator) 
 
e. Coverage of iron-folic acid supplements for pregnant 
women (%) 
 
f. Percentage of health facilities meeting service specific 
readiness requirements 
•Percentage of population with shortfalls of: 
iron, zinc, iodine, vitamin A, folate, vitamin B12, 
[and vitamin D] 
• Percentage children born with low birth 
weight 
•Proportion of infants 6–23 months of age who 
receive a minimum acceptable diet 
•Percentage children born with low birth 
weight 
•Percentage of births attended by skilled 
health personnel (MDG Indicator) 
•Antenatal care coverage (at least one visit and 
at least four visits) (MDG Indicator) 
•Post-natal care coverage (one visit) (MDG 
Indicator) 
•Coverage of iron-folic acid supplements for 
pregnant women (%) 
•Incidence rate of diarrheal disease in children 
under 5 years 
•Percentage of 1 year-old children immunized 
against measles (MDG Indicator) 
•Percent HIV+ pregnant women receiving 
PMTCT 
•Condom use at last high-risk sex (MDG 
Indicator) 
•Percentage of tuberculosis cases detected and 
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cured under directly observed treatment short 
course (MDG Indicator) 
•Percentage of children under 5 with fever who 
are treated with appropriate anti-malarial 
drugs (MDG Indicator) 
• Percentage of people in malaria-endemic 
areas sleeping under insecticide-treated bed 
nets (modified MDG Indicator) 
• Percentage of confirmed malaria cases that 
receive first-line antimalarial therapy according 
to national policy 
• Percentage of suspected malaria cases that 
receive a parasitological test 
• Percentage of pregnant women receiving 
malaria IPT (in endemic areas) 
• Neglected Tropical Disease (NTD) cure rate 
• Incidence and death rates associated with 
hepatitis 
•Percentage of women with cervical cancer 
screening 
• Percentage of adults with hypertension 
diagnosed & receiving treatment 
• Harmful use of alcohol 
•Healthy life expectancy at birth 
• Waiting time for elective surgery 
• Prevalence of insufficient physical activity 
• Fraction of calories from saturated fat and 
added sugar 
•Age-standardized mean population intake of 
salt (sodium chloride) per day in grams in 
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persons aged 18+ years 
• Prevalence of persons (aged 18+ years) 
consuming less than five total servings (400 
grams) of fruit and vegetables per day 
• Percentage change in per capita [red] meat 
consumption relative to a 2015 baseline 
• Age-standardized (to world population age 
distribution) prevalence of diabetes (preferably 
based on HbA1c), hypertension, cardiovascular 
disease, and chronic respiratory disease. 
• [Mortality from indoor air pollution] – to be 
developed 
• Percentage of health facilities meeting service 
specific readiness requirements. 
• Percentage of population with access to 
affordable essential drugs and commodities on 
a sustainable basis 
• Percentage of new health care facilities built 
in compliance with building codes and 
standards 
• Public and private R&D expenditure on health 
(% GNP) 
• Ratio of health professionals to population 
(MDs, nurse midwives, nurses, community 
health workers, EmOC caregivers) 
• Percentage of women and men aged 15–49 
who report discriminatory attitudes towards 
people living with HIV 
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  By 2030 end 
preventable 
deaths of 
newborns and 
under-5 children 
a. Percentage of infants under 6 months who are 
exclusively breast 
fed 
 
b. Neonatal, infant, and under-5 mortality rates 
(modified MDG 
Indicator) 
 
c. Percent of children receiving full immunization (as 
recommended by national vaccination schedules) 
 
d. Percentage of births attended by skilled health 
personnel (MDG 
Indicator)  
e. Antenatal care coverage (at least one visit and at least 
four 
visits) (MDG Indicator) 
 
f. Post-natal care coverage (one visit) (MDG Indicator) 
 
g. Incidence rate of diarrheal disease in children under 5 
years 
 
h. Percentage of children under 5 with fever who are 
treated 
with appropriate anti-malarial drugs (MDG Indicator) 
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  By 2030 end the 
epidemics of 
AIDS, 
tuberculosis, and 
neglected 
tropical diseases 
and combat 
hepatitis, water-
borne diseases, 
and other 
communicable 
diseases 
a. Percent of children receiving full immunization (as 
recommended by national vaccination schedules 
 
b. HIV incidence, treatment rate, and mortality 
(modified MDG Indicator) 
 
c. Incidence, prevalence, and death rates associated 
with all forms of TB (MDG Indicator) 
 
d. Incidence and death rates associated with malaria 
(MDG 
Indicator) 
 
e. [Consultations with a licensed provider in a health 
facility or in the community per person, per year] – to be 
developed 
 
f.[Percentage of population without effective financial 
protection or health care, per year] – to be developed 
 
g. Incidence rate of diarrheal disease in children under 5 
years 
 
h. Percentage of 1 year-old children immunized against 
measles (MDG Indicator) 
 
i. Percent HIV+ pregnant women receiving PMTCT 
 
j. Condom use at last high-risk sex (MDG Indicator) 
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k. Percentage of tuberculosis cases detected and cured 
under directly observed treatment short course (MDG 
Indicator) 
 
l. Percentage of children under 5 with fever who are 
treated 
with appropriate anti-malarial drugs (MDG Indicator). 
 
m. Percentage of people in malaria-endemic areas 
sleeping under insecticide-treated bed nets (modified 
MDG Indicator). 
 
n. Percentage of confirmed malaria cases that receive 
first-line antimalarial therapy according to national 
policy. 
 
o. Percentage of suspected malaria cases that receive a 
parasitological test. 
 
p. Percentage of pregnant women receiving malaria IPT 
(in 
endemic areas) 
 
q. Neglected Tropical Disease (NTD) cure rate 
 
r. Incidence and death rate associated with hepatitis 
 
s. Percentage of women and men aged 15-49 who 
report 
discriminatory attitudes towards people living with HIV 
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  By 2030 reduce 
by one-third pre-
mature mortality 
from non-
communicable 
diseases (NCDs) 
through 
prevention and 
treatment, and 
promote mental 
health and 
wellbeing 
a. Probability of dying between exact ages 30 and 70 
from any of cardiovascular disease, cancer, diabetes, 
chronic respiratory disease, [or suicide]  
 
b. Percent of population overweight and obese, 
including children under 5 
 
c. [Consultations with a licensed provider in a health 
facility or in the community per person, per year] – to be 
developed 
 
d. Proportion of persons with a severe mental disorder 
(psychosis, bipolar affective disorder, or moderate-
severe depression) who are using services 
 
e. Current use of any tobacco product (age-standardized 
rate) 
 
f. Percentage of women with cervical cancer screening  
 
g. Percentage with hypertension diagnosed & receiving 
treatment 
h. Waiting time for elective surgery 
 
i. Prevalence of insufficient physical activity 
 
j. Fraction of calories from saturated fat and added sugar 
 
k. Age-standardized mean population intake of salt 
(sodium chloride) per day in grams in persons aged 18+ 
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years 
 
l. Prevalence of persons (aged 18+ years) consuming less 
than five total servings (400 grams) of fruit and 
vegetables per day 
 
m. Percentage change in per capita [red] meat 
consumption relative to a 2015 baseline 
 
n. Age-standardized (to world population age 
distribution) prevalence of diabetes (preferably based 
on HbA1c), hypertension, cardiovascular disease, and 
chronic respiratory disease. 
  Strengthen 
prevention and 
treatment of 
substance abuse, 
including narcotic 
drug abuse and 
harmful use of 
alcohol 
a. Current use of any tobacco product (age-standardized 
rate) 
 
b. Harmful use of alcohol 
 
  By 2030 halve 
global deaths 
from road traffic 
accidents 
a. Road traffic deaths per 100,000 population  
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  By 2030 ensure 
universal access 
to sexual and 
reproductive 
health care 
services, 
including for 
family planning, 
information and 
education, and 
the integration of 
reproductive 
health into 
national 
strategies and 
programs 
a. Total fertility rate 
 
b. Contraceptive prevalence rate (MDG Indicator) 
 
c. Met demand for family planning (modified MDG 
Indicator)  
 
d. Adolescent birth rate (MDG Indicator) 
 
e. Percentage of young people receiving comprehensive 
sexuality 
education 
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  Achieve universal 
health coverage 
(UHC), including 
financial risk 
protection, 
access to quality 
essential health 
care services, and 
access to safe, 
effective, quality, 
and affordable 
essential 
medicines and 
vaccines for all 
a. Percent of children receiving full immunization (as 
recommended by national vaccination schedules) 
 
b. [Consultations with a licensed provider in a health 
facility or in the community per person, per year] – to be 
developed 
 
c. [Percentage of population without effective financial 
protection or health care, per year] – to be developed 
 
d. Healthy life expectancy at birth 
 
d. Waiting time for elective surgery  
e. Percentage of health facilities meeting service specific 
readiness requirements 
 
f. Percentage of population with access to affordable 
essential drugs and commodities on a sustainable basis 
 
g. Percentage of new health care facilities built in 
compliance with building codes and standards 
 
h. Ratio of health professionals to population (MDs, 
nurse midwives, nurses, community health workers, 
EmOC caregivers) 
 
  By 2030 
substantially 
reduce the 
number of deaths 
and illnesses 
a. Mean urban air pollution of particulate matter (PM10 
and PM2.5) 
 
b. [Mortality from indoor air pollution] – to be 
developed 
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from hazardous 
chemicals and air, 
water, and soil 
pollution and 
contamination 
 
c. [Indicator on chemical pollution] – to be developed 
  A strengthen 
implementation 
of the Framework 
Convention on 
Tobacco Control 
in all countries as 
appropriate 
a. Current use of any tobacco product (age-standardized 
rate) 
 
  Support research 
and development 
of vaccines and 
medicines for the 
communicable 
and non-
communicable 
diseases that 
primarily affect 
developing 
countries, 
provide access to 
affordable 
essential 
medicines and 
vaccines, in 
accordance with 
the Doha 
a. Percentage of population with access to affordable 
essential drugs and commodities on a sustainable basis 
 
b. Public and private R&D expenditure on health (% 
GNP)  
 
c. [Indicator on technology sharing and diffusion] – to be 
developed 
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Declaration 
which affirms the 
right of 
developing 
countries to use 
to the full the 
provisions in the 
TRIPS agreement 
regarding 
flexibilities to 
protect public 
health and, in 
particular, 
provide access to 
medicines for all 
  Increase 
substantially 
health financing 
and the 
recruitment, 
development and 
training and 
retention of the 
health workforce 
in developing 
countries, 
especially in LDCs 
and SIDS  
a. Official development assistance and net private grants 
as 
percent of GNI 
 
b. Domestic revenues allocated to sustainable 
development as 
percent of GNI, by sector  
 
c. Public and private R&D expenditure on health (% GNP) 
 
d. Ratio of health professionals to population (MDs, 
nurse 
midwives, nurses, community health workers, EmOC 
caregivers) 
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  Strengthen the 
capacity of all 
countries 
particularly 
developing 
countries, for 
early warning risk 
reduction, and 
management of 
national and 
global health 
risks 
a. Official development assistance and net private grants 
as 
percent of GNI 
 
b. Domestic revenues allocated to sustainable 
development as percent of GNI, by sector  
 
c. Public and private R&D expenditure on health (% GNP) 
 
d. Ratio of health professionals 
 
5 Achieve gender 
equality and 
empower all 
women and girls 
Eliminate all 
forms of violence 
against all 
women and girls 
in public and 
private spheres, 
including 
trafficking and 
sexual and other 
types of 
exploitation 
a. Prevalence of girls and women 15-49 who have 
experienced 
 
  Eliminate all 
harmful 
practices, such as 
child, early and 
forced marriage 
and female 
genital 
a. Percentage of women aged 20-24 who were married 
or in a union before age 18 
 
b. Percentage of girls and women aged 15-49 years who 
have undergone FGM/C 
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mutilations 
  Ensure universal 
access to sexual 
and reproductive 
health and 
reproductive 
rights as agreed 
in accordance 
with the 
Programme of 
Action of the 
ICPD and the 
Beijing Platform 
for Action and 
the outcome 
documents of 
their review 
conferences 
a. Met demand for family planning (modified MDG 
Indicator) 
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6. Ensure 
availability and 
sustainable 
management of 
water and 
sanitation for all 
By 2030, achieve 
universal and 
equitable access 
to safe and 
affordable 
drinking water for 
all 
a. Percentage of population using safely managed water 
services, by urban/rural (modified MDG Indicator) 
 
b. Percentage of wastewater flows treated to national 
standards [and reused] – to be developed 
 
c. Proportion of total water resources used (MDG 
Indicator) 
 
d. Percentage of population with basic hand washing 
facilities with soap and water at home 
 
e. Percentage of pupils enrolled in primary schools and 
secondary schools providing basic drinking water, 
adequate sanitation, and adequate hygiene services. 
 
d. Percentage of beneficiaries using hospitals, health 
centers and clinics providing basic drinking water, 
adequate sanitation, and adequate hygiene 
•Percentage of young people receiving 
comprehensive sexuality education 
•Percentage of population practicing open 
defecation 
•Percentage of population with basic hand 
washing facilities with soap and water at home 
• Proportion of the population connected to 
collective sewers or with on-site storage of all 
domestic wastewaters 
• Percentage of pupils enrolled in primary 
schools and secondary schools providing basic 
drinking water, adequate sanitation, and 
adequate hygiene services. 
• Percentage of beneficiaries using hospitals, 
health centers and clinics providing basic 
drinking water, adequate sanitation, and 
adequate hygiene 
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  by 2030, achieve 
access to 
adequate and 
equitable 
sanitation and 
hygiene for all, 
and end open 
defecation, 
paying special 
attention to the 
needs of women 
and girls and 
those in 
vulnerable 
situations  
a. Percentage of population using safely managed 
sanitation services, by urban/rural (modified MDG 
Indicator) 
 
b. Percentage of population practicing open defecation 
 
c. Percentage of population with basic hand washing 
facilities with soap and water at home 
 
d. Proportion of the population connected to collective 
sewers or with on-site storage of all domestic 
wastewaters 
 
e. Percentage of pupils enrolled in primary schools and 
secondary schools providing basic drinking water, 
adequate sanitation, and adequate hygiene services. 
 
f. Percentage of beneficiaries using hospitals, health 
centers and clinics providing basic drinking water, 
adequate sanitation, and adequate hygiene 
 
7 Ensure access to 
affordable, 
reliable, 
sustainable and 
modern energy 
for all 
by 2030 ensure 
universal access 
to affordable, 
reliable, and 
modern energy 
services 
a. Share of the population using modern cooking 
solutions, by urban/rural  
 
b, Share of the population using reliable electricity, by 
urban/rural 
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9 Build resilient 
infrastructure, 
promote 
inclusive and 
sustainable 
industrialization 
and foster 
innovation 
Develop quality, 
reliable, 
sustainable and, 
resilient 
infrastructure, 
including regional 
and trans-border 
infrastructure, to 
support 
economic 
development and 
human well-
being, with a 
focus on 
affordable and 
equitable access 
for all 
a. Percentage of population using safely managed water 
services, 
by urban/rural (modified MDG Indicator) 
 
b. Percentage of population using basic sanitation 
services, by 
urban/rural (modified MDG Indicator) 
 
c. Share of the population using modern cooking 
solutions, by 
urban/rural 
 
d. Share of the population using reliable electricity, by 
urban/rural 
 
e. Access to all-weather road (% access within [x] km 
distance to 
road) 
 
f. Mobile broadband subscriptions per 100 inhabitants, 
by 
urban/rural 
 
g. Index on ICT maturity 
 
h. Percentage of households with Internet, by type of 
service by urban/rural areas 
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11 Make cities and 
human 
settlements 
inclusive, safe, 
resilient and 
sustainable 
by 2030, ensure 
access for all to 
adequate, safe 
and affordable 
housing and basic 
services, and 
upgrade slums 
a. Percentage of eligible population covered by national 
social 
protection programs  
 
b. [Consultations with a licensed provider in a health 
facility or the 
community per person, per year] – to be developed 
 
c. Percentage of population using safely managed water 
services, 
by urban/rural (modified MDG Indicator 
 
d. Percentage of population using basic sanitation 
services, by 
urban/rural (modified MDG Indicator 
 
e. Share of the population using modern cooking 
solutions, by 
urban/rural 
 
f. Share of the population using reliable electricity, by 
urban/rural 
 
g. Percentage of urban population living in slums or 
informal 
settlements (MDG Indicator) 
 
16 Promote 
peaceful and 
inclusive 
societies for 
Significantly 
reduce all forms 
of violence and 
related death 
a. Violent injuries and deaths per 100,000 population 
b. Number of refugees 
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sustainable 
development, 
provide access to 
justice for all and 
build effective, 
accountable and 
inclusive 
institutions at all 
levels 
rates everywhere 
  By 2030 provide 
legal identity for 
all including free 
birth registrations 
a. Percentage of children under age 5 whose birth is 
registered with a civil authority 
 
17 Strengthen the 
means of 
implementation 
and revitalize the 
global 
partnership for 
sustainable 
development  
by 2030, build on 
existing initiatives 
to develop 
measurements of 
progress on 
sustainable 
development that 
complement 
GDP, and support 
statistical 
capacity building 
in developing 
countries 
a. Evaluative Wellbeing and Positive Mood Affect  
 Source; Secretary General of the United Nations (2015) Indicators and a Monitoring Framework for the 
Sustainable Development Goals. (accessed 25/09/2015) Available from: http://unsdsn.org/wp-
content/uploads/2015/05/150612-FINAL-SDSN-Indicator-Report1.pdf 
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Annex 3. Workshop participants 
 
Workshop Name Country 
First workshop: ISAGS. Rio de Janeiro, 
Brazil 
1. Cesar Cabral Paraguay 
2. Andrés Coitiño Uruguay 
3. Mariana Faria Brazil 
4. Henri Jouval Brazil 
5. Tomás Pippo Argentina 
6. Marcelo Rojas Bolivia 
7. Delia Sánchez Uruguay 
8. Katherine Tobar Ecuador 
9. José Ueleres Brazil  
SecondWorkshop: UNASUR. Ciudad 
Mitad del Mundo, Ecuador 
1. Elena Clavell Uruguay 
2. Mariana Faria Brazil 
3. Gustavo Giler Ecuador 
4. Jaqueline Lozano Ecuador 
5. Santiago López Ecuador 
6. Cristina Luna Ecuador 
7. Tomás Pippo Argentina 
8. Marcelo Rojas Bolivia 
Third workshop: FLACSO-Argentina. 
Buenos Aires, Argentina 
1. Elena Clavell Uruguay 
2. Mariana Faria  Brazil 
3. Gustavo Giler Ecuador 
4. Cecilia Irazusta Paraguay 
5. Tomás Pippo Argentina 
6. Marcelo Rojas Bolivia 
7. José Ueleres Brazil  
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